Quarterly Report • Nov 12, 2020
Quarterly Report
Open in ViewerOpens in native device viewer

Summary 3 Financial highlights 4 Overview of results and balance sheet 5 Analysis of the quarter 6 Analysis of the year-to-date period 9 Risk statement, economic views and guidance 10
Consolidated income statement 13 Consolidated statement of comprehensive income 15 Consolidated balance sheet 16 Consolidated statement of changes in equity 17 Consolidated cashflow statement 20 Notes on statement of compliance and changes in accounting policies 22 Notes on segment reporting 29 Other notes 30
Credit risk 42 Solvency 48 Income statement, volumes and ratios per business unit 53 Details of ratios and terms 61

The expectations, forecasts and statements regarding future developments that are contained in this report are, of course, based on assumptions and are contingent on a number of factors that will come into play in the future. Consequently, the actual situation may turn out to be (substantially) different.
[email protected] KBC Group NV, Investor Relations Office, Havenlaan 2, 1080 Brussels, Belgium
This report contains information that is subject to transparency regulations for listed companies. Date of release: 12 November 2020
'I, Rik Scheerlinck, Chief Financial Officer of the KBC Group, certify on behalf of the Executive Committee of KBC Group NV that, to the best of my knowledge, the abbreviated financial statements included in the quarterly report are based on the relevant accounting standards and fairly present in all material respects the financial condition and results of KBC Group NV including its consolidated subsidiaries, and that the quarterly report provides a fair view of the main events, the main transactions with related parties in the period under review and their impact on the abbreviated financial statements, and an overview of the main risks and uncertainties for the remainder of

| KBC Group – overview (consolidated, IFRS) | 3Q2020 | 2Q2020 | 3Q2019 | 9M2020 | 9M2019 |
|---|---|---|---|---|---|
| Net result (in millions of EUR) | 697 | 210 | 612 | 902 | 1 787 |
| Basic earnings per share (in EUR) | 1.64 | 0.47 | 1.44 | 2.08 | 4.19 |
| Breakdown of the net result by business unit (in millions of EUR) | |||||
| Belgium | 486 | 204 | 368 | 605 | 932 |
| Czech Republic | 116 | 77 | 159 | 281 | 584 |
| International Markets | 123 | -45 | 85 | 113 | 260 |
| Group Centre | -28 | -26 | 0 | -97 | 10 |
| Parent shareholders' equity per share (in EUR, end of period) | 46.6 | 44.9 | 43.5 | 46.6 | 43.5 |
During the third consecutive quarter of facing up to the challenges of the pandemic, the harsh reality that coronavirus is still far from being eradicated has become very clear. It is still causing human suffering all over the world and unprecedented economic upheaval. However, the various government relief measures should help control the overall impact going forward. Obviously, the long-term impact of the coronavirus crisis on society will be significant. It will also depend on the number and intensity of any new outbreaks, as well as on the timing of developing and distributing a vaccine or cure.
Meanwhile, we have been working hard with government agencies to support all customers impacted by coronavirus, by efficiently implementing various relief measures, including loan deferrals. In our six home countries combined, we have granted a total of 13.7 billion euros in loan payment deferrals by the end of September 2020 (according to the EBA definition) and have also granted 0.6 billion euros' worth of loans under public corona guarantee schemes. At the same time, we have continued providing a high level of service to our customers in all our core markets, thanks to the expertise and commitment of our employees, in combination with the efforts and investments we have made over the past few years on the digital transformation front. Given that the pandemic has accelerated the trend to digitalisation, we are clearly benefiting from our digital transformation efforts. We will continue to work on solutions to proactively make life easier for our customers, thanks in part to the extensive use of artificial intelligence and data analysis. We will be communicating on this and other topics in more depth during a separate strategy session today, with the accompanying press release being issued at 1 p.m. CET.
As regards our financial results, we generated a net profit of 697 million euros in the third quarter of 2020, leading to a return on equity of 15% in the third quarter of 2020 (when bank taxes are spread evenly throughout the year). The third quarter profit is well above the 210 million euros recorded in the previous quarter, which had included 746 million euros in collective impairment charges for the coronavirus crisis. Our net interest income went up quarter-on-quarter, while our trading and fair value result fared well too, though it was down on the exceptionally high level recorded in the previous quarter. In the current lower-for-longer interest rate environment, this quarterly result is also clearly benefiting from the diversification achieved through KBC's integrated bank-insurance model. This was reflected in a strong non-life result (good premium growth and an excellent combined ratio of 83% year-to-date), as well as higher net fee and commission income. Costs remained clearly under control. Adding the result for this quarter to the one for the first half of the year brings our net profit for the first nine months of 2020 to 902 million euros.
Our solvency position remained very strong, with a common equity ratio of 16.6% on a fully loaded basis, well above the current minimum capital requirement of 7.95%. Our liquidity position remained solid too, with an LCR of 142% and an NSFR of 146% at the end of September 2020. Consequently, our current capital and liquidity buffers allow us to face today's

challenges with confidence.
In closing, I would like to take this opportunity to explicitly thank all stakeholders who have continued to put their trust in us. I also wish to express my sincere thanks to all colleagues who have expended huge efforts to serve our customers and support the sound functioning of the group in these challenging times.
Johan Thijs, Chief Executive Officer


KBC Group I Quarterly Report – 3Q2020 I p.3
697 390 225 85 -926 Other income 1 122 Net interest income Net fee and commission income Technical insurance income Trading & FV income 50 Operating expenses Net result Other -63 Impairment -2 -184 Income taxes Breakdown of 3Q2020 result (in millions of EUR) Belgium; 486 Czech Republic; 116 International Markets; 123 Group Centre; -28 Contribution of the business units to 3Q2020 group result (in millions of EUR)
| Consolidated income statement, IFRS KBC Group (in millions of EUR) |
3Q2020 | 2Q2020 | 1Q2020 | 4Q2019 | 3Q2019 | 9M2020 | 9M2019 |
|---|---|---|---|---|---|---|---|
| Net interest income | 1 122 | 1 083 | 1 195 | 1 182 | 1 174 | 3 400 | 3 436 |
| Non-life insurance (before reinsurance) | 233 | 255 | 185 | 229 | 192 | 673 | 527 |
| Earned premiums | 448 | 435 | 443 | 441 | 440 | 1 327 | 1 280 |
| Technical charges | -215 | -180 | -258 | -212 | -248 | -654 | -753 |
| Life insurance (before reinsurance) | 1 | 6 | 0 | 2 | -5 | 6 | -7 |
| Earned premiums | 267 | 276 | 297 | 364 | 291 | 841 | 959 |
| Technical charges Ceded reinsurance result |
-266 -9 |
-271 -13 |
-297 -7 |
-363 -11 |
-297 -9 |
-834 -30 |
-966 -14 |
| Dividend income | 12 | 17 | 12 | 17 | 14 | 41 | 65 |
| Net result from financial instruments at fair value through P&L1 | 85 | 253 | -385 | 130 | -46 | -47 | 51 |
| Net realised result from debt instruments at fair value through | |||||||
| other comprehensive income | 1 | 2 | 0 | 0 | 5 | 4 | 7 |
| Net fee and commission income | 390 | 388 | 429 | 445 | 444 | 1 207 | 1 289 |
| Net other income | 37 | 53 | 50 | 47 | 43 | 139 | 234 |
| Total income | 1 872 | 2 043 | 1 479 | 2 041 | 1 813 | 5 394 | 5 588 |
| Operating expenses | -926 | -904 | -1 338 | -1 045 | -975 | -3 168 | -3 258 |
| Impairment | -63 | -857 | -141 | -82 | -26 | -1 060 | -134 |
| Of which: on financial assets at amortised cost and at fair value through other comprehensive income2 |
-52 | -845 | -121 | -75 | -25 | -1 018 | -128 |
| Share in results of associated companies & joint ventures | -2 | -3 | -3 | -1 | 0 | -9 | 8 |
| Result before tax | 881 | 279 | -3 | 912 | 812 | 1 157 | 2 204 |
| Income tax expense | -184 | -69 | -2 | -210 | -200 | -255 | -417 |
| Result after tax | 697 | 210 | -5 | 702 | 612 | 902 | 1 787 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 697 | 210 | -5 | 702 | 612 | 902 | 1 787 |
| Basic earnings per share (EUR) | 1.64 | 0.47 | -0.04 | 1.66 | 1.44 | 2.08 | 4.19 |
| Diluted earnings per share (EUR) | 1.64 | 0.47 | -0.04 | 1.66 | 1.44 | 2.08 | 4.19 |
| Key consolidated balance sheet figures KBC Group (in millions of EUR) |
30-09-2020 | 30-06-2020 | 31-03-2020 | 31-12-2019 | 30-09-2019 | ||
| Total assets | 321 193 | 317 388 | 301 451 | 290 735 | 294 830 | ||
| Loans and advances to customers, excl. reverse repos | 157 773 | 157 563 | 158 364 | 155 816 | 154 863 | ||
| Securities (equity and debt instruments) | 71 310 | 72 131 | 67 176 | 65 633 | 65 122 | ||
| Deposits from customers & debt certificates, excl. repos | 211 672 | 210 811 | 208 293 | 203 369 | 205 270 | ||
| Technical provisions, before reinsurance | 18 613 | 18 775 | 18 816 | 18 560 | 18 549 | ||
| Liabilities under investment contracts, insurance | 12 482 | 12 505 | 11 979 | 13 610 | 13 456 | ||
| Parent shareholders' equity | 19 384 | 18 710 | 18 220 | 18 865 | 18 086 | ||
| Selected ratios KBC group (consolidated) |
9M2020 | FY2019 | |||||
| Return on equity | 6%3 | 14% | |||||
| Cost/income ratio, banking | 61% | 58% | |||||
| (when excluding certain non-operating items and spreading bank taxes evenly throughout the year) |
(59%) | (58%) | |||||
| Combined ratio, non-life insurance | 83% | 90% | |||||
| Common equity ratio, Basel III Danish Compromise, fully loaded [transitional] | 16.6% [16.6%] | 17.1% | |||||
| Common equity ratio, FICOD fully loaded [transitional] | 15.5% [15.5%] | 15.8% | |||||
| Leverage ratio, Basel III fully loaded | 5.9% | 6.8% | |||||
| Credit cost ratio | 0.61% | 0.12% | |||||
| Impaired loans ratio | 3.2% | 3.5% | |||||
| for loans more than 90 days past due | 1.8% | 1.9% | |||||
| Net stable funding ratio (NSFR) | 146% | 136% | |||||
| Liquidity coverage ratio (LCR) | 142% | 138% |
1 Also referred to as 'Trading and fair value income'.
2 Also referred to as 'Loan loss impairment'. 3 This is 7% when bank taxes are spread evenly throughout the year.
We provide a full overview of our IFRS consolidated income statement and balance sheet in the 'Consolidated financial statements' section of the quarterly report. Condensed statements of comprehensive income, changes in shareholders' equity, as well as several notes to the accounts, are also available in the same section. As regards the (changes in) definition of ratios, see 'Details of ratios and terms' in the quarterly report.
1 872 million euros
Net interest income amounted to 1 122 million euros in the quarter under review, up 4% on the figure recorded in the previous quarter and down 4% year-on-year. The quarter-on-quarter increase was due mainly to the positive impact of TLTRO III, a positive one-off item related to inflation-linked bonds (insurance), higher margins on the new production of mortgage loans than the margins on the outstanding portfolios in Belgium, the Czech Republic and Slovakia, and the higher netted impact of ALM FX swaps. These items more than offset the negative impact of the rate cuts made in the past by the CNB in the Czech Republic and the lower reinvestment yields in general. Year-on-year, the decrease was mainly related to the past CNB rate cuts in the Czech Republic, the year-on-year depreciation of the Czech koruna and Hungarian forint against the euro and the negative impact of lower reinvestment yields, which could not be fully offset by the positive impact of TLTRO III, the above-mentioned positive oneoff item, ECB tiering and a larger loan and bond portfolio.
The total volume of customer lending (158 billion euros) was up 1% quarter-on-quarter and 4% year-on-year, with year-on-year growth recorded in all business units. The volume of granted loans with payment holidays in the various relief schemes amounted to 13.7 billion euros by the end of September 2020 according to the EBA definition (broken down evenly among home loans, SME loans and loans to corporations). For approximately 1 billion euros of that amount, the moratorium has already expired by the end of September 2020 (of which 97% resumed payments). In addition to this, we granted some 0.6 billion euros in loans that fall under the various corona-related government guarantee schemes in our home markets.
Customer deposits including debt certificates (212 billion euros) were up 1% quarter-on-quarter and 4% year-on-year, with yearon-year growth in all business units. Excluding debt certificates, deposits were up by no less than 9% year-on-year. All growth figures disregard forex movements.
The net interest margin for the quarter under review amounted to 1.81%, down 1 and 13 basis points, respectively, on the figures recorded in the previous and year-earlier quarters.
Technical income from our non-life insurance activities (earned premiums less technical charges, plus the ceded reinsurance result) contributed 225 million euros to total income, down 9% on the excellent performance recorded in the previous quarter and up 22% on the corresponding year-earlier quarter. Notwithstanding higher earned premium income, the quarter-on-quarter nonlife technical income decrease came about primarily because of higher technical charges (claims gradually returning to more normal levels following the exceptionally low level in the second quarter as a consequence of the lockdown). The year-on-year increase was due to a combination of lower charges and higher premium income. Overall, the combined ratio for the first nine months of 2020 came to an excellent 83%, compared to 90% for full-year 2019.
Technical income from our life insurance activities (earned premiums less technical charges, plus the ceded reinsurance result) amounted to 0 million euros, compared to 1 million euros in the previous quarter and -6 million euros in the year-earlier quarter. Sales of life insurance products in the quarter under review (420 million euros) were down 25% on the level recorded in the previous quarter, due to lower sales of both unit-linked and guaranteed-interest life products in Belgium. Sales were up 4% on the level recorded in the year-earlier quarter, driven by higher sales of unit-linked products in Belgium (due to the shift from mutual funds to unit-linked products by private banking customers) and only partially offset by lower sales of guaranteed-interest products (due mainly to the suspension of universal single life insurance in Belgium). Overall, in the quarter under review, both unit-linked products and guaranteed-interest products accounted for approximately half of our total life insurance sales.
In the quarter under review, net fee and commission income amounted to 390 million euros. This figure was slightly up (1%) on the level of the previous quarter, with the increase in fees for our asset management business (higher management fees) more than offsetting the higher level of distribution fees paid for non-life insurance products (higher sales), with fee income from our banking activities remaining stable (recovery of payment transaction fees largely offset by a decrease in securities-related fees). Compared to the year-earlier quarter, net fee and commission income was down 12%, due to a combination of lower asset management related fees, lower fees for banking services (especially for payment services), higher distribution fees paid and the year-on-year depreciation of the Czech koruna and Hungarian forint against the euro. At the end of September 2020, our total assets under management amounted to 204 billion euros, up 1% quarter-on-quarter but down 4% year-on-year. The quarter-onquarter increase was due to a further recovery in asset prices (+1%), combined with a limited net inflow in mutual funds. The yearon-year decrease resulted mainly from lower asset prices.
The net result from financial instruments at fair value (trading and fair value income) amounted to 85 million euros, continuing its recovery from the very negative level in the first quarter (-385 million euros), though much less so than the exceptional rebound recorded in the second quarter. Consequently, it was down 168 million euros on the very high level recorded in that second quarter (lower dealing room results, lower amount resulting from market value adjustments and lower result of the insurance share portfolio) and up 131 million euros year-on-year (thanks mainly to higher dealing room results and a higher amount resulting from market value adjustments).
The other remaining income items included dividend income of 12 million euros, down on the figure recorded in the previous quarter (as the second quarter of the year traditionally includes the bulk of received dividends), and also slightly down on the yearearlier figure. The remaining income lines also included 37 million euros in net other income, somewhat below the normal run rate for this item as, among other things, it included a negative 6 million euros for the tracker mortgage review in Ireland (4 million euros of which relating to the tracker mortgage fine).
Operating expenses in the third quarter of 2020 amounted to 926 million euros. Excluding bank taxes, this constitutes an increase of 3% compared to the low level recorded in the second quarter of 2020. This was due to a number of factors, including higher staff expenses (wage inflation and the fact that the previous quarter had benefited from a decrease in accruals for variable remuneration), increased marketing costs (seasonal), higher facilities expenses and higher depreciation expenses. These items were not fully offset by the positive impact of, inter alia, a decrease in FTEs and a reduction in ICT and professional fees. Year-on-year, expenses excluding bank taxes were down 4%, thanks essentially to lower staff expenses (lower accruals for variable remuneration and a decrease in FTEs), lower ICT costs, some direct coronavirus crisis impact (lower facilities, marketing and professional fees) and the year-on-year depreciation of the Czech koruna and Hungarian forint against the euro. These items more than offset the negative impact of wage drift and increased depreciation costs, among other things.
The cost/income ratio of our banking activities came to 61% for the first nine months of 2020. Excluding certain non-operating items and spreading bank taxes evenly throughout the year, the ratio amounted to 59%, more or less in line with the 58% recorded for full-year 2019.
| Loan loss impairment | • | Net loan loss impairment charges significantly down on their level in the previous quarter, which had included 746 million euros in collective impairment charges related to the coronavirus crisis. |
|---|---|---|
| 52-million-euro charge |
• | Credit cost ratio for the first nine months at 0.61%. |
In the third quarter of 2020, we recorded a 52-million-euro net loan loss impairment charge, compared with a net charge of 845 million euros in the previous quarter and 25 million euros in the third quarter of 2019. The huge drop compared to the previous quarter came about because the second quarter had included 746 million euros in collective impairment charges for the coronavirus crisis. In the third quarter, this amount was adjusted slightly (reduced by 5 million euros, following updated macroeconomic forecasts and management overlay), bringing the collective impairment charges related to the coronavirus crisis for the first nine months to 784 million euros. Of this amount, 637 million euros was based on a 'management overlay' and 147 million euros captured by the ECL models through updated macroeconomic variables. A detailed calculation and background information regarding collective impairment charges for the coronavirus crisis is provided in Note 1.4 of the 'Consolidated financial statements' section of the quarterly report.
Broken down by country, loan loss impairment charges in the third quarter of 2020 came to 41 million euros in Belgium, 15 million euros in the Czech Republic, 2 million euros in Bulgaria and 2 million euros for the Group Centre, while both Slovakia and Hungary recorded small net reversals of impairment (5 million euros and 3 million euros, respectively).
For the entire group, the credit cost ratio amounted to 0.61% for the first nine months of 2020 (0.17% excluding the amount recorded for the coronavirus crisis), up from 0.12% for full-year 2019. The impaired loans ratio was down on its level at the start of the year: at the end of September 2020, some 3.2% of our total loan book was classified as impaired (Stage 3), compared to 3.5% at year-end 2019. Impaired loans that are more than 90 days past due amounted to 1.8% of the loan book, compared to 1.9% at year-end 2019.
For an indication of the expected impact of loan loss impairment for full-year 2020, see 'Guidance' on page 11 of this publication.
Impairment on assets other than loans amounted to 11 million euros, compared to 12 million euros in the previous quarter and 1 million euros in the third quarter of 2019. The figure for the quarter under review included several small items (4 million euros of which resulting from an impairment on a lease contract relating to a head-office building in Hungary), whereas the figure for the previous quarter had related primarily to the accounting treatment of payment moratoria in our various countries.
| Net result | Belgium | Czech Republic | International Markets | Group Centre |
|---|---|---|---|---|
| by business unit | 486 | 116 | 123 | -28 |
| million euros | million euros | million euros | million euros |
Belgium: the net result (486 million euros) went up by 282 million euros quarter-on-quarter, due mainly to the drop in loan loss impairment compared to the significant amount recorded in the second quarter, which comprised 378 million euros in collective impairment charges for the coronavirus crisis. Other items accounting for the quarter-on-quarter difference were higher net interest income and lower trading and fair value income (compared to the high level recorded in the second quarter). Net fee and commission income and costs remained virtually unchanged.
Czech Republic: the net result (116 million euros) was up 50% on its level for the previous quarter, due mainly to significantly lower loan loss impairment charges, as the second quarter had included 152 million euros in collective impairment charges for the coronavirus crisis. This more than offset the quarter-on-quarter decrease in net interest income, trading and fair value income and technical insurance result, and the increase in expenses (compared to the very low level in the second quarter).
International Markets: the 123-million-euro net result breaks down as follows: 33 million euros in Slovakia, 51 million euros in Hungary, 27 million euros in Bulgaria and 13 million euros in Ireland. For the business unit as a whole, the net result was up 169 million euros quarter-on-quarter. This increase came about mainly on account of lower loan loss impairment charges in all countries, as the second quarter had included 215 million euros in collective impairment charges for the coronavirus crisis.
Group Centre: the net result (-28 million euros) was slightly lower (-2 million euros) than the figure recorded in the previous quarter, with the drop in trading and fair value income, lower ceded reinsurance result and higher costs being partly offset by higher net interest income (TLTRO III).
| Belgium | Czech Republic | International Markets | ||||
|---|---|---|---|---|---|---|
| Selected ratios by business unit | 9M2020 | FY2019 | 9M2020 | FY2019 | 9M2020 | FY2019 |
| Cost/income ratio, banking (excluding certain non-operating items and spreading bank taxes evenly throughout the year) |
57% | 60% | 51% | 47% | 66% | 68% |
| Combined ratio, non-life insurance | 83% | 89% | 87% | 94% | 82% | 88% |
| Credit cost ratio* | 0.59% | 0.22% | 0.64% | 0.04% | 0.79% | -0.07% |
| Impaired loans ratio | 2.2% | 2.4% | 2.1% | 2.3% | 7.2% | 8.5% |
* A negative figure indicates a net impairment release (positively affecting results). See 'Details of ratios and terms' in the quarterly report.
A full results table is provided in the 'Additional information' section of the quarterly report. A short analysis of the results per business unit is provided in the analyst presentation (available at www.kbc.com).
| Equity, solvency and liquidity |
Total equity |
Common equity ratio (fully loaded) |
Liquidity coverage ratio |
Net stable funding ratio |
|---|---|---|---|---|
| 20.9 billion euros | 16.6% | 142% | 146% |
At the end of September 2020, total equity amounted to 20.9 billion euros, comprising 19.4 billion euros in parent shareholders' equity and 1.5 billion euros in additional tier-1 instruments. Total equity was up 0.5 billion euros on its level at the end of 2019. This was due to the combined effect of a number of items, including the profit for the nine-month period (+0.9 billion euros), a decrease in the revaluation reserves for equity instruments of the insurance company (the so-called 'insurance overlay approach'; -0.1 billion euros), an increase in the revaluation reserve for bonds (+0.1 billion euros), translation differences (-0.4 billion euros, due to the depreciation of the Czech koruna and Hungarian forint in the period under review) and a number of minor items. We have provided details of these changes under 'Consolidated statement of changes in equity' in the 'Consolidated financial statements' section of the quarterly report.
At 30 September 2020, our fully loaded common equity ratio (Basel III, under the Danish compromise) amounted to a solid 16.6%, stable compared to three months earlier (despite 1 billion euros in RWA add-ons for anticipated PD-migrations) and down somewhat on the 17.1% recorded at the end of 2019 (due chiefly to the absence of IFRS interim profit recognition). Our fully loaded leverage ratio (Basel III) came to 5.9%, compared to 6.8% at the end of 2019. The solvency ratio for KBC Insurance under the Solvency II framework was 196% at the end of September 2020, compared to 202% at the end of 2019.
Our liquidity position remained excellent too, as reflected in an LCR ratio of 142% and an NSFR ratio of 146% at the end of the quarter under review (compared to 138% and 136%, respectively, at the end of 2019).
| Net result | • • |
Net result down by half on the corresponding period of 2019. Loan loss impairment charges significantly up, as they included 784 million euros in collective impairment charges for the coronavirus crisis. |
|---|---|---|
| 902 million euros |
• • |
Net interest income, net fee and commission income, trading and fair value income, dividend income and net other income down. Technical insurance result up and costs down. |
Highlights (compared to the first nine months of 2019):
As we are mainly active in banking, insurance and asset management, we are exposed to a number of typical risks for these financial sectors such as – but not limited to – credit default risk, counterparty credit risk, concentration risk, movements in interest rates, currency risk, market risk, liquidity and funding risk, insurance underwriting risk, changes in regulations, operational risk, customer litigation, competition from other and new players, as well as the economy in general. KBC closely monitors and manages each of these risks within a strict risk framework, but they may all have a negative impact on asset values or could generate additional charges beyond anticipated levels.
At present, a number of items are considered to constitute the main challenges for the financial sector. These stem primarily from the impact of the coronavirus crisis on the global economy and, in particular, the financial sector (including credit, market and liquidity risks and the impact of persisting low interest rates on our results). These risks come on top of risks relating to macroeconomic and political developments, such as Brexit and trade conflicts, all of which affect global and European economies, including KBC's home markets. Regulatory and compliance risks (including anti-money laundering regulations and GDPR) remain a dominant theme for the sector, as does enhanced consumer protection. Digitalisation (with technology as a catalyst) presents both opportunities and threats to the business model of traditional financial institutions, while climate-related risks are becoming increasingly prevalent. Finally, cyber risk has become one of the main threats during the past few years, not just for the financial sector, but for the economy as a whole.
We provide risk management data in our annual reports, quarterly reports and dedicated risk reports, all of which are available at www.kbc.com.
Growth in the euro area and US bounced back strongly in the third quarter of 2020, as did KBC's home markets. It followed the sharp contraction in the second quarter caused by the pandemic and subsequent policy responses, which led to a lockdown of large parts of the economy. Therefore, the robust third-quarter growth figures largely represent a mechanical impact of economies opening up again, supported by massive monetary and fiscal stimulus packages. The Chinese economy is a notable frontrunner in the recovery cycle, as it returned to positive growth as early as the second quarter of 2020.
However, the pace of this recovery should be treated with caution. First of all, economic activity is still below pre-pandemic levels in both the service and manufacturing sectors, underlining the fact that there is still a long way to go to full recovery. Secondly, forward looking indicators point to downside risks with regard to the strength of the continued recovery in the fourth quarter of 2020 and the first quarter of 2021. In particular, the recovery in the service sector seems to be losing strength of late, with the manufacturing sector still showing some resilience.
The ongoing second wave of the pandemic is also leading to policy responses such as renewed partial or full lockdowns, which will at least temporarily disrupt the road to recovery. Such temporary restrictive policy measures are already being implemented in many European countries. The respective governments are, however, doing their best to limit the direct impact of these measures on economic activity as much as possible.
The other main risk factors to recovery include the Brexit transition phase ending without an EU-UK agreement, as well as renewed tensions in the economic conflict between the US and China.
The US and euro area economies are strongly supported by monetary and fiscal stimuli. We expect the Fed and the ECB to keep their policy rates unchanged in the years to come. Additional quantitative easing by the ECB is likely, with the size and duration of the Pandemic Emergency Purchasing Programme probably being extended. These market interventions will help to preserve the low longer-term interest rate environment for even longer and compress intra-EMU spreads – and Bulgarian sovereign spreads – in the coming years.
The Hungarian central bank recently tightened its policy stance to support the weakening exchange rate of the Hungarian forint against the euro. This depreciation was largely the result of increased global risk aversion. We expect the tightening to be a temporary policy measure, as the forint is forecast to appreciate to a certain extent again in the fourth quarter of 2020. The Czech koruna has also weakened against the euro, which – like the forint – is likely to be a temporary situation. We expect the Czech National Bank (CNB) to keep its policy rate unchanged. If the CNB decides to intervene, it is more likely to use unconventional policy measures.
Since August, the exchange rate of the US dollar has broadly stabilised against the euro, after having weakened significantly over a number of months previously. We expect the dollar to resume its gradual depreciation against the euro in the fourth quarter of 2020, since a major driving force behind the euro – real interest rate differentials – is expected to remain in place.
| Guidance | • Full-year 2020 guidance: |
|---|---|
| ▪ Net interest income: approximately 4.5 billion euros (increased from the 4.4 billion euros stated in the previous quarterly report); |
|
| ▪ Operating expenses excluding bank taxes: decrease of approximately 3.5% year-on-year; |
|
| ▪ Loan loss impairment: approximately 1.1 billion euros. Depending on a number of events such as the length and depth of the economic downturn, the significant number of government measures in each of our core countries, and the unknown number of customers who will call upon these mitigating actions, we estimate loan loss impairment for full-year 2020 to range between approx. 0.8 billion euros (optimistic scenario) and approx.1.6 billion euros (pessimistic scenario); |
|
| • The impact of the coronavirus lockdown on digital sales, services and digital signing has so far been very positive. KBC is clearly benefiting from the digital transformation efforts it has made to date; |
|
| • Basel IV has been postponed by one year (as of 1 January 2023 instead of 2022); | |
| • We will provide a strategy update today, while new long-term financial guidance and our capital deployment plan will be updated when the results for full-year 2020 are published (11 February 2021). |
__
| Upcoming events |
Strategy update: 12 November 2020, 1 p.m. CET 4Q2020 results and updated new long-term financial guidance & capital deployment plan: 11 February 2021 1Q2021 results: 11 May 2021 |
|---|---|
| More information on 3Q2020 |
Quarterly report: www.kbc.com / Investor Relations / Reports Company presentation: www.kbc.com / Investor Relations / Presentation |
| Detailed impact of coronavirus crisis |
Quarterly report, Note 1.4 in 'Consolidated financial statements according to IFRS' Company presentation, section 2 on 'Covid-19' |
| Definitions of ratios |
'Details of ratios and terms at KBC Group level' in the last section of the quarterly report. |
Consolidated financial statements according to IFRS
3Q 2020 and 9M 2020

Section reviewed by the Auditor
AC: Amortised Cost AFS: Available For Sale (IAS 39) ALM: Asset Liability Management ECL: Expected Credit Loss FA: Financial Assets FV: Fair Value FVA: Funding Value Adjustment FVO: Fair Value Option (designated upon initial recognition at Fair Value through Profit or Loss) FVOCI: Fair Value through Other Comprehensive Income FVPL: Fair Value through Profit or Loss FVPL – overlay: Fair Value through Profit or Loss - overlay GCA: Gross Carrying Amount HFT: Held For Trading MFVPL: Mandatorily Measured at Fair Value through Profit or Loss (including HFT) OCI: Other Comprehensive Income POCI: Purchased or Originated Credit Impaired Assets SPPI: Solely payments of principal and interest SRB: Single Resolution Board R/E: Retained Earnings
| (in millions of EUR) | Note | 9M 2020 | 9M 2019 | 3Q 2020 | 2Q 2020 | 3Q 2019 |
|---|---|---|---|---|---|---|
| Net interest income | 3.1 | 3 400 | 3 436 | 1 122 | 1 083 | 1 174 |
| Interest income | 3.1 | 4 800 | 5 435 | 1 468 | 1 497 | 1 806 |
| Interest expense | 3.1 | - 1 400 | - 1 999 | - 346 | - 415 | - 632 |
| Non-life insurance (before reinsurance) | 3.7 | 673 | 527 | 233 | 255 | 192 |
| Earned premiums | 3.7 | 1 327 | 1 280 | 448 | 435 | 440 |
| Technical charges | 3.7 | - 654 | - 753 | - 215 | - 180 | - 248 |
| Life insurance (before reinsurance) | 3.7 | 6 | - 7 | 1 | 6 | - 5 |
| Earned premiums | 3.7 | 841 | 959 | 267 | 276 | 291 |
| Technical charges | 3.7 | - 834 | - 966 | - 266 | - 271 | - 297 |
| Ceded reinsurance result | 3.7 | - 30 | - 14 | - 9 | - 13 | - 9 |
| Dividend income | 41 | 65 | 12 | 17 | 14 | |
| Net result from financial instruments at fair value through profit or loss | 3.3 | - 47 | 51 | 85 | 253 | - 46 |
| of which result on equity instruments (overlay approach) | - 37 | 65 | 13 | 31 | 17 | |
| Net realised result from debt instruments at fair value through OCI | 4 | 7 | 1 | 2 | 5 | |
| Net fee and commission income | 3.5 | 1 207 | 1 289 | 390 | 388 | 444 |
| Fee and commission income | 3.5 | 1 763 | 1 833 | 575 | 559 | 629 |
| Fee and commission expense | 3.5 | - 556 | - 543 | - 184 | - 172 | - 185 |
| Net other income | 3.6 | 139 | 234 | 37 | 53 | 43 |
| TOTAL INCOME | 5 394 | 5 588 | 1 872 | 2 043 | 1 813 | |
| Operating expenses | 3.8 | - 3 168 | - 3 258 | - 926 | - 904 | - 975 |
| Staff expenses | 3.8 | - 1 703 | - 1 755 | - 564 | - 545 | - 585 |
| General administrative expenses | 3.8 | - 1 191 | - 1 244 | - 267 | - 270 | - 299 |
| Depreciation and amortisation of fixed assets | 3.8 | - 274 | - 260 | - 96 | - 89 | - 90 |
| Impairment | 3.10 | - 1 060 | - 134 | - 63 | - 857 | - 26 |
| on financial assets at AC and at FVOCI | 3.10 | - 1 018 | - 128 | - 52 | - 845 | - 25 |
| on goodwill | 3.10 | 0 | 0 | 0 | 0 | 0 |
| other | 3.10 | - 42 | - 6 | - 11 | - 12 | - 1 |
| Share in results of associated companies and joint ventures | - 9 | 8 | - 2 | - 3 | 0 | |
| RESULT BEFORE TAX | 1 157 | 2 204 | 881 | 279 | 812 | |
| Income tax expense | 3.12 | - 255 | - 417 | - 184 | - 69 | - 200 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | |
| RESULT AFTER TAX | 902 | 1 787 | 697 | 210 | 612 | |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | |
| of which relating to discontinued operations | 0 | 0 | 0 | 0 | 0 | |
| attributable to equity holders of the parent | 902 | 1 787 | 697 | 210 | 612 | |
| of which relating to discontinued operations | 0 | 0 | 0 | 0 | 0 | |
| Earnings per share (in EUR) | ||||||
| Ordinary | 2.08 | 4.19 | 1.64 | 0.47 | 1.44 | |
| Diluted | 2.08 | 4.19 | 1.64 | 0.47 | 1.44 |
The equity instruments of the insurance companies within the group are designated under the overlay approach. These equity instruments, mainly classified as AFS under IAS 39, would have been measured at fair value through P&L under IFRS 9. The overlay approach reclassifies from the income statement to OCI the extra volatility related to the adoption of IFRS 9 as long as IFRS 17 is not in place, until 31 December 2022 (subject to EU endorsement).
The extra volatility due to IFRS 9, reclassified out of the net result from financial instruments at fair value through profit or loss to the revaluation reserves of equity instruments (overlay approach) refers to the unrealised fair value fluctuations amounting to -81 million euros in 9M 2020. It can be summarized as the difference between :
| (in millions of EUR) | 9 M 2020 | 9M 2019 | 3Q 2020 | 2Q 2020 | 3Q 2019 |
|---|---|---|---|---|---|
| RESULT AFTER TAX | 902 | 1787 | 697 | 210 | 612 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 902 | 1 787 | 697 | 210 | 612 |
| OCI THAT MAY BE RECYCLED TO PROFIT OR LOSS | - 319 | 559 | 20 | 406 | વેરૂ |
| Net change in revaluation reserve (FVOCI debt instruments) | 90 | 658 | 80 | 192 | 239 |
| Net change in revaluation reserve (FVPL equity instruments) - overlay | 81 - |
150 | 5 | 138 | 11 |
| Net change in hedging reserve (cashflow hedges) | 10 | - 173 | 29 | 5 | 73 l |
| Net change in translation differences | - 440 | 86 | 131 | 86 | 81 |
| Hedge of net investments in foreign operations | ರಿಗಿ | 8 | 34 | 15 l |
2 |
| Net change in respect of associated companies and joint ventures | 0 | 6 | 0 | 0 | 4 |
| Other movements | 3 | 3 | 2 | 0 | 5 |
| OCI THAT WILL NOT BE RECYCLED TO PROFIT OR LOSS | 31 | 3 | 35 | - 110 | |
| Net change in revaluation reserve (FVOCI equity instruments) | 5 | 16 | 6 | 3 | 5 |
| Net change in defined benefit plans | 39 | 12 - |
41 - |
- 98 | 1 |
| Net change in own credit risk | 5 | 1 | 1 | 13 - |
1 |
| Net change in respect of associated companies and joint ventures | 2 | 0 | 0 | 2 | 0 |
| TOTAL COMPREHENSIVE INCOME | 552 | 2 349 | 682 | 506 | 712 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 552 | 2 349 | 682 | 506 | 711 |
The largest movements in other comprehensive income (9M 2020 vs. 9M 2019):
| ASSETS Cash, cash balances with central banks and other demand deposits with credit institutions 28 227 8 356 Financial assets 4.0 283 008 273 399 Amortised cost 4.0 238 147 230 639 Fair value through OCI 4.0 18 603 19 037 Fair value through profit or loss 4.0 26 060 23 563 of which held for trading 4.0 10 922 7 266 Hedging derivatives 4.0 198 158 Reinsurers' share in technical provisions, insurance 132 121 Fair value adjustments of the hedged items in portfolio hedge of interest rate risk 1 563 478 Tax assets 1 571 1 396 Current tax assets 107 96 Deferred tax assets 1 464 1 300 Non-current assets held for sale and disposal groups 19 29 Investments in associated companies and joint ventures 24 25 Property, equipment and investment property 3 602 3 818 Goodwill and other intangible assets 1 681 1 640 Other assets 1 365 1 474 TOTAL ASSETS 321 193 290 735 LIABILITIES AND EQUITY Financial liabilities 4.0 278 043 248 400 Amortised cost 4.0 255 763 224 093 Fair value through profit or loss 4.0 20 893 23 137 of which held for trading 4.0 6 764 6 988 Hedging derivatives 4.0 1 387 1 171 Technical provisions, before reinsurance 18 613 18 560 Fair value adjustments of the hedged items in portfolio hedge of interest rate risk 254 - 122 Tax liabilities 470 478 |
|---|
| Current tax liabilities 65 98 |
| Deferred tax liabilies 405 380 |
| Provisions for risks and charges 216 227 |
| Other liabilities 2 713 2 827 |
| TOTAL LIABILITIES 300 309 270 371 |
| Total equity 5.10 20 884 20 365 |
| Parent shareholders' equity 5.10 19 384 18 865 |
| Additional tier-1 instruments included in equity 5.10 1 500 1 500 |
| Minority interests 0 0 |
| TOTAL LIABILITIES AND EQUITY 321 193 290 735 |
| (in millions of EUR) | Issued and paid up share capital |
Share premium |
Treasury shares |
Retained earnings |
Total revaluation reserves |
Parent shareholders equity |
Additional tier-1 instruments included in equity |
Minority interests |
Total equity |
|---|---|---|---|---|---|---|---|---|---|
| 30-09-2020 | |||||||||
| Balance at the end of the previous period | 1 458 | 5 498 | 2 - |
11 875 | 37 | 18 865 | 1 500 | 0 | 20 365 |
| Net result for the period | 0 | 0 | 0 | 902 | 0 | 902 | O | 0 | 902 |
| Other comprehensive income for the period | 0 | O | 0 | 3 | 353 | 351 | O | 0 | 351 l |
| Subtotal | 0 | 0 | 0 | 905 | 353 l |
552 | O | 0 | 552 |
| Dividends | 0 | 0 | 0 | 0 | O | 0 | O | 0 | 0 |
| Coupon on AT1 | O | O | 0 | 34 । |
0 | 34 I |
O | 0 | 34 - |
| Transfer from revaluation reserves to retained earnings on realisation | 0 | O | 0 | 22 | 22 I |
0 | 0 | 0 | 0 |
| Purchase/sale of treasury shares | 0 | 0 | 1 | 0 | 0 | 1 | O | 0 | 1 |
| Change in minorities interests | O | O | 0 | 0 | 0 | 0 | O | 0 | 0 |
| Total change | 0 | 0 | 1 | 893 | 375 l |
519 | O | 0 | 519 |
| Balance at the end of the period | 1 458 | 5 498 | 1 । |
12 768 | 339 | 19 384 | 1 500 | 0 | 20 884 |
| 2019 | |||||||||
| Balance at the end of the previous period | 1 457 | 5 482 | ਤ - |
10 901 | ୧୦୧ l |
17 233 | 2 400 | 0 | 19 633 |
| Net result for the period | 0 | O | O | 2 489 | 0 | 2 489 | O | 0 | 2 489 |
| Other comprehensive income for the period | 0 | 0 | 0 | 3 । |
640 | 637 | 0 | 0 | 637 |
| Subtotal | 0 | 0 | 0 | 2 486 | 640 | 3 126 | O | 0 | 3 126 |
| Dividends | 0 | 0 | 0 | - 1 457 | 0 | - 1 457 | O | 0 | - 1 457 |
| Coupon on AT1 | 0 | 0 | 0 | 52 ı |
0 | 52 । |
O | 0 | 52 l |
| Issue/repurchase of AT1 included in equity | 0 | 0 | 0 | 2 | 0 | 2 । |
900 - |
0 | 902 । |
| Capital increase | 1 | ન ર | 0 | 0 | 0 | 16 | O | 0 | 1 ર |
| Transfer from revaluation reserves to retained earnings on realisation | 0 | 0 | 0 | 1 l |
1 | 0 | O | 0 | 0 |
| Purchase/sale of treasury shares | 0 | 0 | 0 | 0 | 0 | 0 | O | 0 | 0 |
| Change in minorities interests | 0 | 0 | 0 | 0 | 0 | 0 | O | 0 | 0 |
| Total change | 1 | ન ર | 0 | 974 | 641 | 1 632 | 900 । |
0 | 732 |
| Balance at the end of the period | 1 458 | 5 498 | 2 l |
11 875 | 37 | 18 865 | 1 500 | 0 | 20 365 |
| (in millions of EUR) | Issued and paid up share capital |
Share premium |
Treasury shares |
Retained earnings |
Total revaluation reserves |
Parent shareholders" equity |
Additional tier-1 instruments included in equity |
Minority interests |
Total equity |
|---|---|---|---|---|---|---|---|---|---|
| 30-09-2019 | |||||||||
| Balance at the end of the previous period | 1 457 | 5 482 | - 3 | 10 901 | ୧୦୧ l |
17 233 | 2 400 | O | 19 633 |
| Net result for the period | 0 | O | 0 | 1 787 | 0 | 1 787 | O | O | 1 787 |
| OCI for the period | O | O | O | - 3 | ૨૯૨ | 562 | O | O | 562 |
| Subtotal | O | 0 | O | 1 783 | રેદર્દ | 2 349 | O | O | 2 349 |
| Dividends | O | O | O | -1 457 | O | - 1 457 | O | O | - 1 457 |
| Coupon on AT1 | O | 0 | 0 | 37 | 0 | - 37 | O | O | - 37 |
| Issue/repurchase of AT1 included in equity | O | 0 | O | - 2 | 0 | - 2 | 900 | O | - 902 |
| Transfer from revaluation reserves to retained earnings on realisation | O | O | O | O | 0 | 0 | O | O | 0 |
| Purchase/sale of treasury shares | O | O | 0 | O | 0 | 0 | O | 0 | O |
| Change in minorities interests | 0 | 0 | O | 0 | 0 | 0 | O | 0 | O |
| Total change | 0 | O | 0 | 287 | રેદર્દ | 853 | 900 | O | - 47 |
| Balance at the end of the period | 1 457 | 5 482 | - 2 | 11 188 | - 39 | 18 086 | 1 500 | O | 19 585 |
Please note that, fully in line with the European Central Bank recommendation, the KBC Board of Directors has decided:
The line 'Dividends' in 9M 2019 includes:
The line 'Issue/repurchase of additional Tier-1 instruments included in equity' in 9M 2019 includes:
| (in millions of EUR) | 30-09-2020 | 31-12-2019 - | 30-09-2019 |
|---|---|---|---|
| Revaluation reserve (FVOCI debt instruments) | 1 081 | 992 | 1 250 |
| Revaluation reserve (FVPL equity instruments) - overlay | 268 | 350 | 309 |
| Revaluation reserve (FVOCI equity instruments) | 14 | 32 | 38 |
| Hedging reserve (cashflow hedges) | - 1321 | - 1331 | 1 436 |
| Translation differences | - 531 | 92 | 160 |
| Hedge of net investments in foreign operations | 188 | 89 | 94 |
| Remeasurement of defined benefit plans | - 39 | O | 131 |
| Own credit risk through OCI | ব | 5 | |
| Total revaluation reserves | - 339 | 37 | - 39 |
| (in millions of EUR) | Note (1) | 9M 2020 | 9M 2019 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Consolidated income | |||
| Result before tax | statement | 1 157 | |
| Adjustments for non-cash items in profit & loss | 1 629 | ||
| Changes in operating assets (excluding cash and cash equivalents) | - 10 104 | ||
| Changes in operating liabilities (excluding cash and cash equivalents) | 31 579 | ||
| Income taxes paid | - 437 | ||
| Net cash from or used in operating activities | 23 824 | - 5 539 | |
| INVESTING ACTIVITIES | |||
| Purchase and proceeds of debt securities at amortised cost | 4.1 | - 4 688 | |
| Acquisition of a subsidiary or a business unit, net of cash acquired (including | |||
| increases in percentage interest held) | O | ||
| Proceeds from the disposal of a subsidiary or business unit, net of cash disposed of | |||
| (including decreases in percentage interest held) | 28 | ||
| Purchase and proceeds from the sale of intangible fixed assets (excluding goodwill) |
- 228 | ||
| Purchase and proceeds from the sale of property, plant and equipment (excluding | |||
| goodwill) | 107 | ||
| Other | 28 | ||
| Net cash from or used in investing activities | -4 753 | 169 | |
| FINANCING ACTIVITIES | |||
| Consolidated | |||
| statement of changes | |||
| Purchase or sale of treasury shares | in equity | 2 | |
| Issue or repayment of promissory notes and other debt securities | 4.1 | 949 | |
| Proceeds from or repayment of subordinated liabilities | 4.1 | - 88 | |
| Principal payments under finance lease obligations | O | ||
| Consolidated | |||
| statement of changes | |||
| Proceeds from the issuance of share capital | in equity | 0 | |
| Consolidated | |||
| Issue of additional tier-1 instruments | statement of changes in equity |
0 | |
| Consolidated | |||
| statement of changes | |||
| Proceeds from the issuance of preference shares | in equity | 0 | |
| Consolidated | |||
| statement of changes | |||
| Dividends paid | in equity | 0 | |
| Consolidated | |||
| statement of changes | |||
| Coupon additional Tier-1 instruments | in equity | - 34 | |
| Net cash from or used in financing activities | 829 | 152 |
| (in millions of EUR) | Note (1) | 9M 2020 | 9M 2019 |
|---|---|---|---|
| CHANGE IN CASH AND CASH EQUIVALENTS | |||
| Net increase or decrease in cash and cash equivalents | 19 900 | - 5 218 | |
| Cash and cash equivalents at the beginning of the period | 29 118 | 34 354 | |
| Effects of exchange rate changes on opening cash and cash equivalents | - 1 786 | - 127 | |
| Cash and cash equivalents at the end of the period | 47 231 | 29 009 | |
| COMPONENTS OF CASH AND CASH EQUIVALENTS | |||
| Cash and cash balances with central banks and other demand deposits with credit | Consolidated | ||
| institutions | balance sheet | 28 227 | 7 758 |
| Term loans to banks at not more than three months (excl. reverse repos) | 4.1 | 1114 | 426 |
| Reverse repos with credit institutions and investment firms at not more than three | |||
| months | 4.1 | 23 351 | 27 017 |
| Deposits from banks repayable on demand | 4.1 | - 5 460 | - 6 192 |
| Cash and cash equivalents belonging to disposal groups | O | O | |
| Total | 47 231 | 29 009 | |
| of which not available | 0 | O |
As of 2020, we provide additional details on the cash flow statement in the interim reporting (not retroactively).
The net cash from operating activities in 9M 2020 (+23 824 million euros) is mainly explained by +19.5 billion euros TLTRO III funding, in combination with the realized result. In 9M 2019, the negative net cash from operating activities (-5 539 million euros) mainly includes the repayment of a part (4 billion euros) of the outstanding TLTRO II in combination with higher term loans and mortgage loans, partly compensated by higher certificates of deposit and the realized result.
Net cash from investing activities in 9M 2020 (-4 753 million euros) is mainly explained by additional investments in debt securities at amortised cost. The net cash from investing activities in 9M 2019 (+169 million euros) can be explained by +439 million euros related to the acquisition of the remaining 45% stake in ČMSS (the acquisition price of 240 million euros is more than compensated by available cash and cash equivalents on the balance sheet of ČMSS) being partly offset by additional investments in debt securities at amortised cost.
The net cash flow from financing activities in 9M 2020 (+829 million euros) mainly includes the issue of Senior Holdco instruments for 1 750 million euros, partly offset by repayments. Matured covered bond position of 1 billion euros in May is fully renewed in June.
In 9M 2019 the net cash flow from financing activities (+152 million euros) includes:
the issue of Tier-2 instruments for 750 million euros in August 2019, in view of the call in November 2019 of the existing 750 million euros Tier-2 instruments, issued in 2014.
The condensed interim financial statements of the KBC Group for the period ended 30 September 2020 have been prepared in accordance with IAS 34, 'Interim financial reporting'. The condensed interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2019, which have been prepared in accordance with the International Financial Reporting Standards as adopted for use in the European Union ('endorsed IFRS').
The following IFRS standards became effective on 1 January 2020 and have been applied in this report:
The following IFRS standards were issued and not yet effective in 2020, but KBC decided to early adopt.
The following IFRS standards were issued but not yet effective in 2020. KBC will apply these standards when they become mandatory.
A summary of the main accounting policies is provided in the group's annual accounts as at 31 December 2019.
Exchange rates used: during 9M 2020, the exchange rates of the CZK and HUF dropped significantly, with negative impact on the balance sheet total and on the result:
The continuing public health crisis around the world has distressed financial markets amid concerns that the global economy, and the EU's economies in particular, are heading towards a sharp contraction in full year 2020. The Coronavirus pandemic has triggered a chain of events in the markets that has led to a sharp increase in volatility.
The significant deterioration in the economic outlook has brought about an unprecedented monetary policy response from central banks and governments around the world.
Meanwhile, we have been working hard with government agencies to support all customers impacted by coronavirus, by efficiently implementing various relief measures, including loan deferrals. In our six home countries combined, we have granted a total of 13.7 billion euros in loan payment deferrals by the end of September 2020 (according to the EBA definition) and have also granted 0.6 billion euros' worth of loans under public Covid-19 guarantee schemes (see on the next page, the latest status of the different government and sector measures in each of our core countries).
Latest status overview of the different government and sector measures in each of our core countries:
| Be lg ium |
ch bli Cze Re pu c |
Slo kia va |
Hu ng ary |
lga ria Bu |
lan Ire d |
|
|---|---|---|---|---|---|---|
| ts n e m y a p f o al rr e f e D |
for Opt ‐in: 3 nth mo s con sum er fina 6‐9 nth for rtga nce mo s mo ges , and ail loa (un til 31 Oct ‐ret non ns, 202 0 and be end ed 31 ext to Dec can 0) 202 priv def l of For ate per son s: erra l and prin cipa inte rest nts, pay me wh ile onl def l of l prin cipa y erra for ail clie nts ‐ret nts pay me non d def l Inte is rest acc rue ove r erra fro fam ilies h iod wit rt net per apa m , of less tha inco 1 700 For me n eur os. the latt this ults in er gro up, res a difi ion loss for the ban k. (‐11 cat mo mil lion Ref in 2Q. to not eur os er e 0) 3.1 |
(ap Opt ‐in: 3 6 nth plic atio or mo s n iod fini she d 30 Sep 202 0, per on how end of Oct 202 0 all eve r def als ired ) err exp lica ble for il and ail App reta ‐ret non clie nts priv and For ate per son s def l of prin cipa l ent rep ren eur s: erra and wh ile onl inte rest nts pay me y , def l of l for prin cipa nts erra pay me ail clie ‐ret nts non d the def l Inte is rest acc rue ove r erra iod but the be paid inte rest st per mu , in the fina l inst alm ulti in ent res ng a , difi ion loss for the ban k (‐5 cat mo mil lion in 2Q. Ref to not eur os er e 0) 3.1 loa the For inte rest con sum er ns, dur the def l iod ing not erra per ma y eed the eek 2‐w 8% rate exc rep o + |
Opt ‐in: 9 nth 6 nth mo s or mo s (for ) lea App lica tion ses – iod is stil l nin (bu t st per run g mo wil l end in 1Q 202 1) lica ble for il App reta tom cus ers , SM and Es ent rep ren eur s Def al of prin cipa l and err inte rest nts pay me is d the Inte rest acc rue ove r def l iod but the erra per , has the of tom opt ion cus er all afte ing inte rest at pay s onc e r the rium ing rato mo or pay on a line bas is. The latt ion opt ar er uld ult in imm rial ate wo res an difi ion loss for the ban k cat mo |
Opt bla nke t: t ‐ou a mo ra‐ ium orig ina lly il 31 Dec tor unt 202 0. Ext ion of the ens def al il 30 202 but unt Jun 1 err wit h tain elig ibil ity crit eria cer (no det aile d legi slat ion ilab le for ail yet ‐ret ava non clie ) nts lica ble for il and App reta non ‐ il clie reta nts Def al of l prin cipa and err inte rest nts pay me d the Inte is rest acc rue ove r def l iod but aid erra per unp , inte be ital ised rest not can cap and be col lect ed st mu on a line bas dur the is ing ar (ext end ed) lifet ain ing ime rem Thi ults difi in ion cat s res a mo loss for the ban k (‐18 mil lion in 1Q; ised ‐11 to eur os rev mil lion in 2Q bas ed eur os on the ual rati Ref act opt t ‐ou o. er 0) 3.1 to not e |
(un Opt ‐in: 6 nth til mo s 31 Ma 202 1 the at r late st) App lica tion – iod ired 30 per exp on Sep 202 0 lica ble for il App reta and il reta non ‐ tom cus ers Def l of l prin cipa erra h hou wit wit t or def l of inte rest erra nts pay me the of l In prin cipa cas e def l onl the ten erra or y, is end ed by 6 ext nth mo s Inte is d rest acc rue ove r the def l iod and erra per abl nth is in 12 pay e mo s (co and nsu me r non ‐ il) 60 nth reta or mo s (mo ) in al rtga ges equ inst alm ent s |
Opt ‐in: 3 6 nth to mo s (ap plic atio iod n per ired 30 Sep 202 0) exp on App lica ble for rtga mo ge loa fina ns, con sum er nce loa and bus ine ns ss ban king loa h wit ns a sch edu le ent rep aym Def l of l and prin cipa erra for inte rest nts pay me up nth (wi th 6 iew to mo s rev afte nth s) for 3 r mo Mo & Con rtga ges sum er fina and 3 nth for nce mo s bus ban king ine ss ion for Opt tom to cus ers end the loa by ir ext ter n m nth tch 6 to to up mo s ma the hol iday nt pay me d Inte is rest acc rue ove r def the l iod erra per |
| e c e n m a e t is h c ss s a e y e t t di n ra ui a q u Li G & |
sch of A sta te tee to gua ran em e up bill loss 40 ion to eur os cov er es rred fut ail loa incu ‐ret on ure non ns bef d 31 Dec ber 202 0 nte gra ore em via ble ies, wit h to ten com pan a or of xim 12 nth ma um mo s. 50% of loss Gua tee ran cov ers es abo of al dit loss and 3% tot ve cre es abo of loss 80% 5% Ma xim ve es. um inte is 1.2 5% rest As of 3Q, ised sta te tee a rev gua ran sch of 10 bill ion to em e up eur os has bee offe red loss to n cov er es on fut loa d bef SM E nte ure ns gra ore ber h 31 Dec 202 0, wit ten em a or bet and 1 3 Gua tee we en yea rs. ran of 80% all loss Ma xim cov ers es. um inte is 2% rest |
The ch‐ ian and Cze Mo Gua tee rav ran elo k (CZ B) Dev Ban MR ent pm lau nch ed l tee sev era gua ran (CO VID II, COV ID II Pra ha, pro gra ms III) COV ID for rkin ital loa wo g cap ns vid ed by rcia l ban ks to pro com me ail clie The loa is ‐ret nts t non n am oun d of the tee to 80% 90% gua ran up or loa (de din the t n am oun pen g on and the of the size pro gra m y). Inte the loa is rest com pan on se ns sub sidi sed 25% (CO VID II) to up The Exp Gua and Insu ort tee ran ran ce Cor atio (EG AP) und its COV ID por n er Plu offe tee s pro gra m rs gua ran s on loa vid ed by l ban ks. rcia ns pro com me of the EGA P tee 70% to 80% gua ran s loa dep end the ing t, n am oun on of the deb The rati is tor ng pro gra m aim ed ies in wh ich at ort com pan exp s ted for tha 20% of acc oun mo re n in 201 9 tur nov er |
i‐Co Ant Gua tee ron a ran offe red by the pro gra m Slo vak Hol din Inv est nt me g (SIH ), and aim ed SM Es, at sist of two ent con s com pon s: (i) 80% wit h stat tee a e gua ran 50% tfo lio and a por cap (ii) the sub sidy of inte rest rate 4% to up p.a add fina l aid the In itio ncia in n, for of the stat tee m e gua ran sch h d fee wit tee em es, gua ran sub sidy be vid ed by can pro (i) the Slov ak Inve stm ent Hol din (gu of nte to g ara e up for loa mil lion 90% 2 < ns os) and eur (ii) the k of Exp Imp Ban ort‐ ort (for loa bet and SR 2 20 ns we en mil lion of tee eur os, gua ran up 80% ). tfo lio is to No por cap lied app |
sch is A tee gua ran em e vid ed by iqa and Gar ant pro the elo Hun ian Dev ent gar pm Ban k. The stat tee se e gua ran s 90% of the to can cov er up loa wit h xim ten ns a ma um or of 6 yea rs the the has Fur MN B rmo re, lau nch ed the din for Fun g wth sch fram rk A gro em e: ewo of bill for 4,2 ion t am oun eur os tha loa SM Es eive t can rec ns wit h 20‐ and ten a yea r or a xim inte of rest rate ma um 2.5 % ual inte Ann rest rate on al loa d by nte per son ns gra l ban ks rcia not com me ma y eed the l ban k bas tra exc cen e by tha (un til 5pp rate mo re n 0) 31 Dec 202 |
bill ion of 0.4 eur os sta te tee gua ran s vid ed by the pro Bul ian gar Dev elo Ban k ent to pm rcia l ban ks. Of com me this billi t, 0.1 am oun on d is to eur os use 100 % tee gua ran on loa wh ile con sum er ns 0.3 bill ion is eur os pla d be d to to nne use 80% tee gua ran on non ‐ il loa reta ns |
The h hor Iris aut itie put s sub l reli ef ntia sta me asu r‐ plac oth esi st n e, am ong er via the SBC I. me asu res, KBC I is inly foc d ma use on ind ivid ual tom cus ers , the refo the reli ef re for bus ine pro gra ms ss less tom cus ers are rele t. van |
| See further in | ||
|---|---|---|
| Items | Impact of the Coronacrisis | note |
| Net interest income | Net interest income was negatively impacted in 9M 2020 following multiple repo rate cuts of the Czech National Bank and in general lower long term interest rates than expected. This was partly compensated by lower funding costs thanks to ECB's TLTRO programme (TLTRO III), while lending income was supported by higher average volumes. |
3.1 |
| Non-life insurance | Exceptionally high technical result in 2Q 2020, supported by a low claims level as a result of the lower economic activity related to the lockdown. |
3.7.1 |
| Life insurance | Challenging context for the sale of life insurance products in view of the low interest rates environment. |
3.7.1 |
| Financial instruments at fair value through P&L |
Financial instruments at fair value through P&L have been negatively affected by the increased volatility in financial markets in 9M 2020, leading to a net result on financial instruments at fair value through profit or loss of -0.05 billion euros in 9M 2020 (-0.4 billion euros in 1Q 2020 due to lower stock markets, widened credit spreads and lower long-term interest rates, largely recovered in 2Q 2020 and 3Q 2020). |
3.3 |
| Net fee and commission income | Net fee and commission income was negatively impacted by the coronavirus pandemic for asset management related fees (lower entry fees due to decreased sales and margins; lower management fees due to a lower average level of assets under management in combination with lower margins). Moreover, fees related to banking services also went down (payment services fees, for instance lower activity level due to the lockdowns). Securities fees on the other hand performed substantially better as transaction volumes typically rise in a more volatile environment. |
3.5 |
| Operating expenses | Significant opex reduction thanks to the various saving measures (which amongst others have resulted in lower provisions for variable remuneration and less FTEs) and lower marketing, travel, facility and event expenses (directly related to a lower activity level due to the lockdowns). |
|
| Impairment on financial assets at AC and at FVOCI |
Strong increase of collective ECL impairments; see separate section below. | 3.10 en 4.2 |
| Impairments on goodwill | We have performed an ad-hoc assessment of goodwill impairment indication. The outcome shows no indication of impairment. |
|
| For UBB and CMSS, the sensitivity analysis shows that structural decreases over the entire forecasting horizon in annual profit of respectively 17% and 12% or increases in annual impairment of respectively 89% and 180% would trigger a goodwill impairment. However, these sensitivities are considered to be too harsh to trigger an impairment in light of the recent situation. For K&H, DZI and CSOB Bank CZ, the impairment buffer is sufficiently large and we do not expect the short-term deviations to trigger an impairment. |
||
| Deferred taxes | We have investigated whether it is probable that taxable profit will be available against which the deductible temporary differences can be utilised based on projections for a period of eight to ten years. The conclusion of this analysis is that there are sufficient estimated taxable profits available. |
|
| Revaluation reserves | Negative net change in revaluation reserve (FVPL equity instruments – overlay approach) and translation differences. |
Consolidated statement of comprehensive income (condensed) |
| Liquidity | KBC has maintained its strong liquidity position throughout the Coronacrisis, supported by KBC's participation in TLTRO III funding. The Liquidity Coverage Ratio (LCR) of KBC Bank, which gives an idea of the bank's liquidity position in the short term, increased in 9M 2020 and amounted to 142% at the end of September 2020 (compared to 138% at the end of December 2019). The Net Stable Funding Ratio (NSFR) of KBC Bank, which gives an idea of the bank's structural liquidity position in the long term, amounted to a high 146% at the end of September 2020 (compared to 136% at the end of December 2019). |
|
| Solvency | Our solvency position remained very strong, with a common equity ratio of 16.6% on a fully loaded basis (compared to 17,1% at the end of 2019). For more information, see part Solvency KBC Group. |
|
| Pending acquisitions | The approval process for the acquisition of OTP Banka Slovensko is still ongoing. |
As disclosed during previous quarters, our Expected Credit Loss (ECL) models were not able to adequately reflect all the specificities of the Covid-19 crisis or the various government measures implemented in the different countries to support households, SMEs and Corporates through this crisis. Therefore, an expert-based calculation at portfolio level is required via a management overlay. In the first quarter, this calculation was limited to a certain number of (sub)sectors. In the second quarter, driven by significant uncertainties around the Covid-19 crisis, the scope of the management overlay was expanded to include all sectors of our Corporate and SME portfolio as well as our retail portfolio. To be consistent with the second quarter, we recalculated the Covid-19 ECL based on the same methodology used on the performing and non-performing portfolio by the end of September 2020 but included the latest economic scenarios.
Until now, only minor PD shifts have been observed in our portfolio, which is reflected in stable staging percentages (for further information, see note 4.2.1).
Note that in line with ECB/ESMA/EBA guidance, any general government measure granted before the end of September 2020 has not led to automatic staging.

For the 30 September performing portfolio, the following 3-step approach was applied to estimate the additional Covid-19 impact:
Compared to the previous quarter, the sector split between high-medium-low risk did not undergo major changes. There were only some minor reallocations of underlying activities from 'high' to 'medium' or even to 'low' risk. Similarly, there were only very limited shifts from 'medium' to 'high' risk, situated mainly in the following sectors:
| ortfolio outstanding | 175 | 180 | 179 | 179 |
|---|---|---|---|---|
| Retail | 42% | 40% | 41% | 42% |
| of which mortgages | 38% | 37% | 38% | 39% |
| of which consumer finance | 3% | 3% | 3% | 3% |
| SME | 22% | 21% | 21% | 22% |
| Corporate | 37% | 39% | 38% | 37% |

*Aligned with the credit risk view of our loan portfolio as reported in the quarterly financial statements.
3) Finally, a probability-weighted management overlay was calculated based on KBC's base-case, optimistic and pessimistic scenarios and attributed weights. An expert-based scaling factor was applied on the estimated sector-driven Covid-19 base-case ECL from the previous step to determine the collective Covid-19 impact under an optimistic and pessimistic scenario. The final overlay was then determined by weighting the resulting Covid-19 ECL under the three scenarios with the following weights: 45% for the base-case, 15% for the optimistic and 40% for the pessimistic scenario.
For the non-performing portfolio, in line with the second quarter, an additional impact assessment was performed on a portfolio basis for the stage 3 collective exposures based on expert judgement of the local credit risk management departments. Additional impairments due to Covid-19 on individually assessed stage 3 loans are already reflected in the specific allowance of the exposure (hence already included in P&L impairments) and thus not included in the management overlay.
| COVID‐19 ECL sector driven – per scenario: | COVID‐19 ECL per country – per scenario: | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The 3-step stress approach applied to the performing portfolio and the additional impact assessment of the non-performing portfolio resulted in a total 9M20 collective Covid-19 ECL of 784 million euros, implying a small P&L release of 5 million euros in 3Q20 compared to the 789 million euros P&L charge of 1H20. The total collective Covid-19 ECL of 784 million euros in 9M20 consists of 6% stage 1, 85% stage 2 and 9% stage 3 impairments.

After 9M, the ECL models captured an impact of 147 million euros through the updated macroeconomic variables used in the calculation (31% in stage 1, 33% in stage 2 and 36% in stage 3), resulting in a q-o-q release of 3 million euros . The total Covid-19 management overlay in the books per 30-09-2020 amounts to 637 million euros, of which 43 million euros was accounted for in 1Q 2020, 596 million euros in 2Q 2020, with a small release of 2 million euros booked in 3Q20. Similar to 1H20, the management overlay is fully presented as stage 2, with the exception of the management overlay on the existing non-performing portfolio.
Including the collective Covid-19 ECL, the Credit Cost Ratio amounted to 0.61%% in 9M20.
| Credit Cost % (annualized*) |
FY19 3M20 | 1H20 | 9M20 | |
|---|---|---|---|---|
| Without collective COVID-19 ECL | 0.12% | 0.17% | 0.20% | 0.17% |
| With collective COVID-19 ECL | 0.27% | 0.64% | 0.61% |
*Collective Covid-19 ECL, not annualized
KBC has formulated three different forecasts that differ on the virus evolution and its impact on the lockdown measures in the different home countries. In short the three scenarios can be summarized as follows:
| OPTIMISTIC SCENARIO | BASE SCENARIO | PESSIMISTIC SCENARIO |
|---|---|---|
| Virus spread and impact sufficiently under control thanks to continued social distancing and other precautionary measures, avoiding the need for another lockdown period |
Virus spread and impact sufficiently under control thanks to continued and possibly intensified social distancing and other precautionary measures, avoiding the need for another full lockdown period |
Virus reappears and continues to weigh on society and economy, necessitating on-off lockdown periods that have a significant impact on economic activity |
| Steep and steady recovery from 3Q20 onwards with a fast return to pre-Covid-19 levels of activity |
More moderate, but still steady recovery from 3Q20 onwards with a recovery to pre-Covid-19 activity levels by end 2023 |
Another (series of) shock(s) takes place, leading to an interrupted and unsteady path to recovery |
| Sharp, short V-pattern | U-pattern | More L-like pattern, with right leg only slowly increasing |
The Covid-19 pandemic continues to be the main driver of the global economy. The epidemiological developments are far from good. The number of new Covid-19 cases are rapidly increasing in many countries. Because of this uncertainty, we continue to work with three alternative scenarios: a base-case scenario, a more optimistic scenario and a more pessimistic scenario. The definition of each scenario reflects the latest virus-related and economic developments, while we continue to assign the same probabilities as in previous quarter: 45% for the base-case, 40% for the pessimistic and 15% for the optimistic scenario.
The following table (in line with the KBC forecast of September 2020) gives these three scenarios for three key indicators (GDP growth, unemployment rate and house price index) for each of our core countries for the next three years*. After that, a gradual linear transition towards a steady state is taken into account. Compared to June 2020, we have revised up euro area GDP growth for 2020 to -8.3% and, mechanically, this less negative outcome for 2020 translates into a downward revision of growth to 5.2% for 2021.
| Macroeconomic base scenario - key indicators (September 2020) |
2020 | 2021 | 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Scenario | Optimistic | Base | Pessimistic | Optimistic | Base | Pessimistic | Optimistic | Base | Pessimistic |
| Real GDP growth | |||||||||
| Euro area | -6.7% | -8.3% | -11.6% | 8.7% | 5.2% | -1.0% | 2 9% | 2.0% | 2 2% |
| Belgium | -6.1% | -9.0% | -11.1% | 9.1% | 5.1% | -1.1% | 2.9% | 2.0% | 2.0% |
| Czech Republic | -6.1% | -7.0% | -8.5% | 6.2% | 4.7% | 1.3% | 2.8% | 3.0% | 3.3% |
| Hungary | -3.0% | -6.2% | -12.0% | 4.0% | 5.0% | 4.0% | 3.5% | 3.5% | 3.5% |
| Slovakia | -6.5% | -8.0% | -9.5% | 6.6% | 6.1% | 1.6% | 4.5% | 3.5% | 3.8% |
| Bulgaria | -4.0% | -8.0% | -12.0% | 4.0% | 5.0% | 4.0% | 3.0% | 3.0% | 3.0% |
| Ireland | 0.0% | -5.0% | -10.0% | 5.0% | 4.0% | 1.0% | 3.0% | 3.5% | 2.5% |
| Unemployment rate | |||||||||
| Belgium | 6.6% | 7.2% | 7.8% | 7.0% | 7.6% | 11.0% | 6.0% | 6.9% | 9.5% |
| Czech Republic | 4.3% | 5.1% | 6.1% | 4.2% | 5.4% | 7.3% | 3.5% | 4.8% | 6.8% |
| Hungary | 4.8% | 6.1% | 7.5% | 4.2% | 5.6% | 7.5% | 4.0% | 4.8% | 6.5% |
| Slovakia | 7.5% | 9.0% | 10.0% | 8.0% | 10.0% | 12.0% | 7.0% | 8.0% | 10.5% |
| Bulgaria | 6.0% | 8.0% | 11.0% | 4.3% | 10.0% | 13.0% | 4.2% | 7.0% | 12.0% |
| Ireland | 8.0% | 11.0% | 20.0% | 6.0% | 7.0% | 16.0% | 5.0% | 6.0% | 12.0% |
| House price index | |||||||||
| Belgium | 1.5% | -0.5% | -1.5% | 1.0% | -3.0% | -6.0% | 2.5% | 1.0% | -2.0% |
| Czech Republic | 5.3% | 4.8% | 3.5% | 1.0% | -0.8% | -4 0% | 4.1% | 2.0% | -0.8% |
| Hungary | 4.0% | 2.0% | -7.5% | 1.0% | -1.0% | -5.0% | 3.1% | 2.0% | -1.0% |
| Slovakia | 6.5% | 5.0% | 2.0% | 1.0% | -1.0% | -5.0% | 3.0% | 2.0% | -0.5% |
| Bulgaria | 0.5% | -2.0% | -3.0% | 1.0% | -1.0% | 1.0% | 3.0% | 3.0% | 1.5% |
| Ireland | -2.0% | -7.0% | -12.0% | 4.0% | 3.5% | 0% | 4.0% | 3.5% | 1.0% |
*The macroeconomic information is based on the economic situation in September 2020 (and include KBC's view on the Brexit outcome) and hence does not yet reflect the official macroeconomic figures for 3Q20 as reported by different authorities.
For a description on the management structure and linked reporting presentation, reference is made to note 2.1 in the annual accounts 2019.
| Czech | International | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| (in millions of EUR) | Belgium | Republic | Markets | ||||||
| Business | Business | Business Of which: | Group | ||||||
| unit | unit | unit | Hungary Slovakia Bulgaria | Ireland | Centre | Total | |||
| 9M 2020 | |||||||||
| Net interest income | 1 948 | 807 | ୧୧୧ | 194 | 151 | 108 | 212 | - 20 | 3 400 |
| Non-life insurance (before reinsurance) | 435 | 105 | 119 | 43 | 23 | 53 | 0 | 14 | 673 |
| Earned premiums | 851 | 225 | 242 | 109 | 39 | 94 | 0 | 10 | 1 327 |
| Technical charges | - 415 | - 120 | - 123 | - 66 | 16 - |
- 41 | 0 | 5 | - 654 |
| Life insurance (before reinsurance) | - 53 | 38 | 22 | 1 | 9 | 11 | 0 | 0 | હ |
| Earned premiums | 615 | 147 | 79 | 26 | 26 | 27 | 0 | 0 | 841 |
| Technical charges | - 668 | - 109 | - 57 | - 25 | - 17 | - 16 | 0 | 0 | - 834 |
| Ceded reinsurance result | - 22 | - 1 | - 7 | - 2 | - 2 | - 3 | 0 | 0 | - 30 |
| Dividend income | 37 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 41 |
| Net result from financial instruments at fair value through profit or loss | - 1 | - 19 | 27 | 24 | 5 | O | 3 - |
- 54 | 47 l |
| Net realised result from debt instruments at fair value through OCI | 1 | O | 2 | 1 | 1 | 0 | 0 | O | 4 |
| Net fee and commission income | 850 | 157 | 203 | 141 | 44 | 20 | 2 - |
4 - |
1 207 |
| Net other income | 116 | 15 | 7 | 3 | 7 | 2 | 6 l |
1 | 139 |
| TOTAL INCOME | 3311 | 1 103 | 1 039 | 406 | 238 | 192 | 201 | - 59 | 5 394 |
| Operating expenses | - 1 868 | - 564 | - 663 | - 244 | - 156 | - 106 | - 157 |
- 72 | - 3 168 |
| lmpairment | - 629 | - 203 | - 236 | - 68 | - 43 | - 30 | - 95 | 7 | - 1 060 |
| of which on FA at amortised cost and at fair value through OCI | - 615 | - 193 | - 216 | - 51 | - 43 | 28 । |
95 - |
7 | - 1 018 |
| Share in results of associated companies and joint ventures | - 8 | - 1 | 0 | 0 | 0 | 0 | 0 | 0 | - 9 |
| RESULT BEFORE TAX | 807 | 335 | 140 | 94 | 39 | 56 | 51 - |
124 - |
1 157 |
| Income tax expense | - 202 | - 54 | - 27 | - 18 | - 9 | - 6 | 6 | 28 | - 255 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT AFTER TAX | ୧୦୧ | 281 | 113 | 76 | 30 | 50 | 45 - |
97 - |
902 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | ୧୦୧ | 281 | 113 | 76 | 30 | 50 | - 45 | - 97 | 902 |
| 9M 2019 | |||||||||
| Net interest income | 1 882 | дзя | 644 | 190 | 153 | 105 | 196 | 29 | 3 436 |
| Non-life insurance (before reinsurance) | 334 | 85 | 102 | 34 | 21 | 47 | 0 | റ | 527 |
| Earned premiums | 829 | 208 | 235 | 109 | 35 | 92 | 0 | 8 | 1 280 |
| Technical charges | - 496 | - 123 | - 133 | - 75 | 14 l |
- 44 | 0 | 2 - |
- 753 |
| Life insurance (before reinsurance) | - 74 | 42 | 25 | 6 | 8 | 11 | 0 | 0 | - 7 |
| Earned premiums | 718 | 170 | 71 | 12 | 31 | 28 | 0 | 0 | ರಿಸಿದ |
| Technical charges | - 792 | - 128 | - 46 | - 7 | - 23 | - 17 | 0 | O | 966 - |
| Ceded reinsurance result | 7 | - 5 | - 8 | - 2 | - 1 | - 5 | 0 | ರಿ l |
- 14 |
| Dividend income | ୧3 | 1 | 0 | 0 | 0 | O | 0 | 2 | ર ર |
| Net result from financial instruments at fair value through profit or loss | 88 | - 93 | 25 | 24 | - 7 | 11 | ਤ - |
31 | ર્દ્રન |
| Net realised result from debt instruments at fair value through OCI | 5 | O | 2 | 1 | 1 | 0 | 0 | 0 | 7 |
| Net fee and commission income | 875 | 195 | 222 | 158 | 48 | 18 | 2 - |
3 - |
1 289 |
| Net other income | 146 | ਰੇਰੇ | - 15 | 1 | 5 | 0 | - 22 | 5 | 234 |
| TOTAL INCOME | 3 326 | 1 263 | 997 | 412 | 229 | 189 | 168 | 2 | ર રેક્ષેત્ |
| Operating expenses | - 1 935 | - 570 | - 685 | - 267 | - 158 | - 106 | - 154 | - 69 | - 3 258 |
| Impairment | - 136 | - 14 | - 5 | 2 | - 16 | - 9 | 18 | 21 | - 134 |
| - 134 | - 11 | - 4 | 3 | - 16 |
- 8 | 18 | 21 | 128 | |
| of which on FA at amortised cost and at fair value through OCI | - 4 | 9 | 4 | 0 | 0 | 0 | 0 | 0 | 8 |
| Share in results of associated companies and joint ventures RESULT BEFORE TAX |
1 251 | 687 | 311 | 147 | 54 | 73 | 33 | - 46 | 2 204 |
| Income tax expense | - 319 | - 103 | - 51 | - 24 | - 13 | - 8 | 7 - |
રેક | - 417 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT AFTER TAX | 932 | 584 | 260 | 124 | 41 | ୧୧ | 27 | 10 | 1 787 |
| attributable to minority interests | 0 932 |
0 | 0 | 0 | 0 | O | O | O | 0 |
| attributable to equity holders of the parent | 584 | 260 | 124 | 41 | 66 | 27 | 10 | 1 787 |
| (in millions of EUR) | 9M 2020 | 9M 2019 | 3Q 2020 | 2Q 2020 | 3Q 2019 |
|---|---|---|---|---|---|
| Total | 3 400 | 3 436 | 1 122 | 1 083 | 1 174 |
| Interest income | 4 800 | 5 435 | 1 468 | 1 497 | 1 806 |
| Interest income on financial instruments calculated using the effective interest rate method | |||||
| Financial assets at AC | 3 739 | 4 147 | 1 171 | 1 181 | 1 404 |
| Financial assets at FVOCI | 248 | 249 | 85 | 80 | 84 |
| Hedging derivatives | 285 | 379 | 49 | 101 | 132 |
| Financial liabilities (negative interest) | 136 | 37 | 81 | 34 | 13 |
| Other | 6 | 11 | 0 | 3 | 0 |
| Interest income on other financial instruments | |||||
| Financial assets MFVPL other than held for trading | 8 | 5 | 3 | 3 | 2 |
| Financial assets held for trading | 378 | 606 | 78 | 95 | 171 |
| Of which economic hedges | 344 | 586 | 65 | 82 | 165 |
| Other financial assets at FVPL | 0 | 0 | 0 | 0 | 0 |
| Interest expense | -1 400 | -1 999 | - 346 | - 415 | - 632 |
| Interest expense on financial instruments calculated using the effective interest rate method | |||||
| Financial liabilities at AC | - 580 | - 965 | - 125 | - 171 | - 294 |
| Financial assets (negative interest) | - 44 | - 60 | - 26 | - 8 | - 12 |
| Hedging derivatives | - 467 | - 498 | - 132 | - 158 | - 167 |
| Other | -5 | -4 | -3 | -1 | -2 |
| Interest expense on other financial instruments | |||||
| Financial liabilities held for trading | - 279 | - 436 | - 57 | - 67 | - 145 |
| Of which economic hedges | - 255 | - 408 | - 50 | - 60 | - 134 |
| Other financial liabilities at FVPL | - 22 | - 30 | - 3 | - 9 | - 10 |
| Net interest expense relating to defined benefit plans | - 2 | - 6 | - 1 | - 1 | - 2 |
The vast majority of negative interest on financial liabilities and financial assets relates to transactions with central banks, interbank and professional counterparties as well as the TLTRO.
| (in millions of EUR) | 9M 2020 9M 2019 3Q 2020 2Q 2020 3Q 2020 3Q 2019 | ||||
|---|---|---|---|---|---|
| Total | - 47 | 51 | 85 | 253 | - 46 |
| Breakdown by driver | |||||
| Market value adjustments (xVA) | - 32 | - 48 -- | 55 | 100 | - 37 |
| MTM ALM derivatives | - 65 | 11 l |
- 2 | - 3 | ા |
| Financial instruments to which the overlay is applied | - 37 | 65 | 13 | 31 | 17 |
| Dealing room and other | 87 | 45 | 19 | 126 | - 25 |
The result from financial instruments at fair value through profit or loss in 3Q 2020 is 168 million euros lower compared to 2Q 2020. The quarter-on-quarter decrease is due to:
The result from financial instruments at fair value through profit or loss in 9M 2020 is 98 million euros lower compared to 9M 2019. This decrease is due to:
| (in millions of EUR) | 9M 2020 | 9M 2019 | 3Q 2020 | 2Q 2020 | 3Q 2019 |
|---|---|---|---|---|---|
| Total | 1 207 | 1 289 | 390 | 388 | 444 |
| Fee and commission income | 1 763 | 1 833 | 575 | 559 | 629 |
| Fee and commission expense | - 556 | - 543 | - 184 | - 172 | - 185 |
| Breakdown by type | |||||
| Asset Management Services | 752 | 809 | 245 | 237 | 275 |
| Fee and commission income | 795 | 850 | 260 | 250 | 288 |
| Fee and commission expense | - 43 | - 41 | - 15 | - 13 | - 13 |
| Banking Services | 666 | 686 | 218 | 219 | 237 |
| Fee and commission income | 909 | 935 | 300 | 291 | 326 |
| Fee and commission expense | - 243 | - 249 | - 81 | - 72 | - 89 |
| Distribution | - 211 | - 207 | - 73 | - 68 | - 68 |
| Fee and commission income | 58 | 47 | 15 | 19 | 15 |
| Fee and commission expense | - 269 | - 254 | - 88 | - 86 | - 83 |
| (in millions of EUR) | 9M 2020 | 9M 2019 | 3Q 2020 | 2Q 2020 | 3Q 2019 |
|---|---|---|---|---|---|
| Total | 139 | 234 | 37 | 53 | 43 |
| of which gains or losses on | |||||
| Sale of financial assets measured at amortised cost | 10 | 11 | 1 | 2 | 7 |
| Repurchase of financial liabilities measured at amortised cost | 0 | 9 | 0 | 0 | 9 |
| of which other, including: | 129 | 215 | 36 | 51 | 27 |
| Income from (mainly operational) leasing activities, KBC Lease Group | 58 | 56 | 20 | 20 | 16 |
| Income from VAB Group | 37 | 33 | 12 | 13 | 11 |
| One-off effect revaluation of 55% share in CMSS | 0 | 82 | 0 | 0 | 0 |
| Settlement of legacy legal cases | 0 | 9 | 0 | 0 | 3 |
| Provisioning for tracker mortgage review | - 6 | - 22 | - 6 | 0 | - 18 |
In 9M 2020
Provision for tracker mortgage review in KBC Bank Ireland of -6 million euros in 3Q 2020 (of which an additional -4 million euro related to the fine).
| Non | ||||
|---|---|---|---|---|
| (in millions of EUR) | Life | Non-life | technical account |
Total |
| 9M 2020 | ||||
| Earned premiums, insurance (before reinsurance) | 841 | 1 341 | - | 2 181 |
| of which change in provision unearned premiums | 0 | - 118 | - 117 | |
| Technical charges, insurance (before reinsurance) | - 834 | - 655 | - | - 1 489 |
| Claims paid | - 867 | - 597 | - | - 1 464 |
| Changes in technical provisions | 47 | - 14 | - | 32 |
| Other technical result | - 13 | - 44 | - | - 57 |
| Net fee and commission income | - 7 | - 257 | - | - 264 |
| Ceded reinsurance result | - 1 | - 28 | - | - 30 |
| General administrative expenses | - 111 | - 185 | - 2 | - 298 |
| Internal claims settlement expenses | - 6 | - 45 | - | - 50 |
| Indirect acquisition costs | - 24 | - 54 | - | - 78 |
| Administrative expenses | - 81 | - 87 | - | - 168 |
| Investment management fees | 0 | 0 | - 2 | - 2 |
| Technical result | - 113 | 215 | - 2 | 100 |
| Investment Income (*) | 250 | 74 | 18 | 343 |
| Technical-financial result | 138 | 289 | 16 | 443 |
| Share in results of associated companies | - | - | 0 | 0 |
| and joint ventures | ||||
| RESULT BEFORE TAX | 138 | 289 | 16 | 443 |
| Income tax expense | - | - | - | - 110 |
| RESULT AFTER TAX | - | - | - | 333 |
| attributable to minority interest | - | - | - | 0 |
| attributable to equity holders | - | - | - | 333 |
| of the parent | ||||
| 9M 2019 | ||||
| Earned premiums, insurance (before reinsurance) | 959 | 1 295 | - | 2 254 |
| of which change in provision unearned premiums | 1 | - 134 | - 133 | |
| Technical charges, insurance (before reinsurance) | - 966 | - 754 | - | - 1 720 |
| Claims paid | - 858 | - 635 | - | - 1 493 |
| Changes in technical provisions | - 154 | - 74 | - | - 228 |
| Other technical result | 46 | - 46 | - | 0 |
| Net fee and commission income | - 21 | - 247 | - | - 268 |
| Ceded reinsurance result | - 2 | - 12 | - | - 14 |
| General administrative expenses | - 115 | - 189 | - 2 | - 307 |
| Internal claims settlement expenses | - 7 | - 45 | - | - 52 |
| Indirect acquisition costs | - 24 | - 54 | - | - 78 |
| Administrative expenses | - 85 | - 90 | - | - 175 |
| Investment management fees | 0 | 0 | - 2 | - 2 |
| Technical result | - 144 | 92 | - 2 | - 55 |
| Investment Income (*) | 374 | 68 | 18 | 460 |
| Technical-financial result | 230 | 160 | 16 | 405 |
| Share in results of associated companies and joint ventures |
– | – | 3 | 3 |
| RESULT BEFORE TAX | 230 | 160 | 19 | 409 |
| Income tax expense | – | – | – | - 89 |
| RESULT AFTER TAX | – | – | – | 320 |
| attributable to minority interest | – | – | – | 0 |
| attributable to equity holders of the parent |
– | – | – | 320 |
(*)9M 2020 consists of (in millions of EUR): Net interest income (347), Net Dividend income (25), Net result from financial instruments at fair value through profit and loss (-27), Net realised result from debt instruments at fair value through OCI (1), Net other income (6) and Impairment (-10). 9M 2019 consists of (in millions of EUR): Net interest income (347), Net Dividend income (40), Net result from financial instruments at fair value
through profit and loss (75), Net realized result from debt instruments at fair value through OCI (1), Net other income (-2) and Impairment (-1). The non-technical account includes also results of non-insurance companies such as VAB group and ADD.
Note: Figures for premiums exclude the investment contracts without DPF (Discretionary Participation Features), which roughly coincide with the unit-linked products. Figures are before elimination of transactions between the bank and insurance entities of the group (more information in the 2019 annual accounts).
In 9M 2020 the technical result non-life was positively impacted by low claim level largely as a result of the lockdown in 2Q 2020, partially offset by storms in mainly Belgium for a total amount of -37 million euros (pre-tax, before reinsurance).
In 9M 2019 the technical result non-life was negatively impacted by:
The operating expenses for 3Q 2020 include 21 million euros related to bank (and insurance) levies (27 million euros in 2Q 2020; 28 million euros in 3Q 2019; 454 million euros in 9M 2020; 440 million euros in 9M 2019). Application of IFRIC 21 (Levies) has as a consequence that certain levies are taken upfront in expense of the first quarter of the year.
| (in millions of EUR) | 9M 2020 | 9M 2019 | 3Q 2020 | 2Q 2020 | 3Q 2019 |
|---|---|---|---|---|---|
| Tota | -1 060 | - 134 | - 63 | - 857 | - 26 |
| Impairment on financial assets at AC and at FVOCI | - 1 018 | - 128 | - 52 | - 845 | 25 l |
| Of which impairment on financial assets at AC | - 1 013 | - 129 | 51 - |
- 842 | 26 । |
| By product | |||||
| Loans and advances | - 997 | - 114 | - 49 | 837 | 19 |
| Debt securities | 0 | 0 | 1 - |
O | 0 |
| Off-balance-sheet commitments and financial guarantees | - 16 | 14 । |
7 - |
- 5 | 7 |
| By type | |||||
| Stage 1 (12-month ECL) | - 64 | 25 | - 4 | 52 | - 8 |
| Stage 2 (lifetime ECL) | - 701 | 11 | - 38 | - 618 | 14 |
| Stage 3 (non-performing; lifetime ECL) | - 246 | - 120 | 11 | - 171 | 32 |
| Purchased or originated credit impaired assets | 1 - |
5 | 2 | - 2 | 0 |
| Of which impairment on financial assets at FVOCI | 5 - |
1 | 1 - |
- 3 | 1 |
| Debt securities | 5 - |
1 | 1 - |
- 3 | 1 |
| Stage 1 (12-month ECL) | 3 - |
O | 1 - |
1 । |
1 |
| Stage 2 (lifetime ECL) | 2 - |
1 | 1 | 2 । |
1 |
| Stage 3 (non-performing; lifetime ECL) | 0 | 0 | 0 | 0 | 0 |
| Impairment on goodwill | 0 | 0 | 0 | 0 | 0 |
| Impairment on other | - 42 | 6 l |
11 - |
- 12 | 1 |
| Intangible fixed assets (other than goodwill) | 5 - |
3 l |
3 l |
- 2 | O |
| Property, plant and equipment (including investment property) | 5 - |
1 l |
4 - |
0 | 0 |
| Associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| Other | - 33 | 2 | 4 - |
அ l |
1 |
The impairments on financial assets at AC in 9M 2020 include -784 million euros collective Covid-19 ECL (of which -43 million euros in 1Q 2020, -746 million euros in 2Q 2020 and +5 million euros in 3Q 2020). For more information, see note 1.4 of this report.
The stage 3 impairments in 9M 2020 and 9M 2019 are attributable mainly to loan loss impairments in Belgium and Czech Republic due to a number of corporate files.
The impairment on other (Other -33 million euros) include -27 million euros in 9M 2020 (respectively -18 and -9 million euros in 1Q and 2Q 2020) related to modification losses in Belgium, Czech Republic and Hungary. Additionally, 3Q 2020 included the result of an impairment on a lease contract related to a headquarter building in Hungary for -4 million euros.
| MEVPL | ||||||||
|---|---|---|---|---|---|---|---|---|
| excl. HEI |
Hedging | |||||||
| and | deriva- | |||||||
| (in millions of EUR) | AC | FVOCI overlay | Overlay | HEI | FVO | tives | Total | |
| FINANCIAL ASSETS, 30-09-2020 Loans and advances to credit institutions and investment firms (excl. |
6 031 | O | O | 0 | 1 | 0 | O | 6 031 |
| reverse repos) | ||||||||
| of which repayable on demand and term loans at not more than three months | 1114 | |||||||
| Loans and advances to customers (excl. reverse repos) | 157 443 | 0 | 330 | 0 | 0 | 0 | O | 157 773 |
| Trade receivables | 1 565 | 0 | O | 0 | 0 | 0 | 0 | 1 565 |
| Consumer credit | 5 252 | 0 | 220 | 0 | 0 | 0 | 0 | 5 473 |
| Mortgage loans | 68 951 | 0 | 102 | 0 | 0 | 0 | 0 | 69 053 |
| Term loans | 69 689 | 0 | 8 | 0 | 0 | 0 | 0 | 69 697 |
| Finance lease | 5 725 | 0 | 0 | 0 | 0 | 0 | 0 | 5 725 |
| Current account advances | 4673 | 0 | 0 | 0 | 0 | 0 | 0 | 4 673 |
| Other | 1 587 | 0 | 0 | 0 | 0 | 0 | 0 | 1 587 |
| Reverse repos | 26 144 | O | 0 | 0 | 285 | 0 | 0 | 26 429 |
| with credit institutions and investment firms | 24 921 | O | 0 | 0 | 285 | 0 | O | 25 206 |
| with customers | 1 223 | 0 | 0 | 0 | 0 | 0 | 0 | 1 223 |
| Equity instruments | 0 | 279 | 7 | 1 167 | 438 | 0 | 0 | 1 891 |
| Investment contracts (insurance) | 0 | O | 13 581 | 0 | O | 0 | 0 | 13 581 |
| Debt securities issued by | 47 093 | 18 324 | રેરે રેજિ | 0 | 3 850 | 0 | 0 | 69 419 |
| Public bodies | 40 812 | 12 349 | 0 | 0 | 3 865 | 0 | 0 | 57 026 |
| Credit institutions and investment firms | 3773 | 2639 | 0 | 0 | 18 | 0 | 0 | 6 430 |
| Corporates | 2 507 | 3 335 | 53 | 0 | ୧୫ | 0 | 0 | 5 963 |
| Derivatives | 0 | O | 0 | 0 | 6 246 | 0 | 198 | 6 443 |
| Other | 1 437 | 0 | 0 | 0 | র্ব | 0 | O | 1 440 |
| Total | 238 147 | 18 603 | 13 971 | 1 167 | 10 922 | 0 | 198 | 283 008 |
| FINANCIAL ASSETS, 31-12-2019 | ||||||||
| Loans and advances to credit institutions and investment firms (excl. reverse repos) |
5 388 | 0 | O | 0 | 1 | 0 | O | 5 399 |
| of which repayable on demand and term loans at not more than three months | 468 | |||||||
| Loans and advances to customers (excl. reverse repos) | 155 598 | 0 | 218 | 0 | 0 | 0 | O | 155 816 |
| Trade receivables | 1 885 | 0 | O | 0 | 0 | 0 | 0 | 1 885 |
| Consumer credit | 5 383 | O | 122 | 0 | 0 | 0 | 0 | ર ૨૦૨ |
| Mortgage loans | 67 711 | 0 | 85 | 0 | 0 | 0 | O | 67 796 |
| Term loans | 68 867 | 0 | 10 | 0 | 0 | 0 | 0 | 68 877 |
| Finance lease | 5 926 | 0 | 0 | 0 | 0 | 0 | 0 | 5 926 |
| Current account advances | 4 979 | O | 0 | 0 | O | 0 | 0 | 4 979 |
| Other | 847 | O | O | O | O | O | O | 847 |
| Reverse repos | 25 596 | O | 0 | 0 | 0 | 0 | 0 | 25 596 |
| with credit institutions and investment firms | 25 445 | 0 | 0 | 0 | 0 | 0 | 0 | 25 445 |
| with customers | 151 | O | O | 0 | O | 0 | O | 151 |
| Equity instruments | O | 249 | 7 | 1 431 | 833 | 0 | 0 | 2 519 |
| Investment contracts (insurance) | 0 | O | 14 584 | O | O | 0 | O | 14 584 |
| Debt securities issued by | 42 998 | 18 788 | 58 | 0 | 1 269 | 0 | O | 63 114 |
| Public bodies | 37 024 | 12 370 | O | O | 1 149 | 0 | O | 50 542 |
| Credit institutions and investment firms | 3632 | 2 753 | 0 | 0 | 20 | 0 | 0 | 6 405 |
| Corporates | 2 343 | 3 666 | 58 | 0 | පිරිම | 0 | O | 6 167 |
| Derivatives | O | 0 | O | 0 | 5 163 | 0 | 158 | 5 322 |
| Other | 1 049 | O | 0 | O | O | 0 | O | 1 049 |
| Total | 230 639 | 19 037 | 14 867 | 1 431 | 7 266 | O | 158 | 273 399 |
| Hedging | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | AC | HFT | FVO | derivatives | Total |
| FINANCIAL LIABILITIES, 30-09-2020 | |||||
| Deposits from credit institutions and investment firms (excl. repos) |
36 204 | O | O | 0 | 36 204 |
| of which repayable on demand | 5 460 | ||||
| Deposits from customers and debt securities (excl. repos) | 209 879 | 146 | 1 647 | 0 | 211 672 |
| Demand deposits | 96603 | 0 | 0 | 0 | 96 603 |
| Time deposits | 13 177 | 30 | 152 | 0 | 13 359 |
| Savings accounts | 72 293 | 0 | 0 | 0 | 72 293 |
| Special deposits | 2 599 | 0 | 0 | 0 | 2 599 |
| Other deposits | 328 | 0 | 0 | 0 | 328 |
| Certificates of deposit | 6627 | 0 | 7 | 0 | 6 635 |
| Savings certificates | 546 | 0 | 0 | 0 | 546 |
| Non-convertible bonds | 15 467 | 116 | 1 341 | 0 | 16 924 |
| Non-convertible subordinated liabilities | 2 238 | 0 | 147 | 0 | 2 385 |
| Repos | 6678 | 20 | 0 | 0 | 6 698 |
| with credit institutions and investment firms | 5513 | 19 | 0 | 0 | 5 532 |
| with customers | 1 165 | 1 | 0 | 0 | 1 166 |
| Liabilities under investment contracts | 0 | 0 | 12 482 | 0 | 12 482 |
| Derivatives | 0 | 5 181 | 0 | 1 387 | 6 568 |
| 0 | 1 418 | 0 | 0 | 1 418 | |
| Short positions | 0 | 11 | 0 | 0 | 11 |
| In equity instruments In debt securities |
0 | 1 406 | 0 | 0 | 1 406 |
| Other | 3 001 | 0 | 0 | 3 001 | |
| 0 | |||||
| Total | 255 763 | 6 764 | 14 129 | 1 387 | 278 043 |
| FINANCIAL LIABILITIES, 31-12-2019 | |||||
| Deposits from credit institutions and investment firms (excl. | 18 731 | 0 | 0 | 0 | 18 731 |
| repos) | |||||
| of which repayable on demand | 4 669 | ||||
| Deposits from customers and debt securities (excl. repos) | 200 607 | 223 | 2 539 | 0 | 203 369 |
| Demand deposits | 85 626 | 0 | 0 | 0 | 85 626 |
| Time deposits | 15271 | 39 | 184 | 0 | 15 494 |
| Savings accounts | 69 057 | 0 | 0 | 0 | 69 057 |
| Special deposits | 2 465 | 0 | O | 0 | 2 465 |
| Other deposits | 542 | 0 | 0 | 0 | 542 |
| Certificates of deposit | 10 538 | 0 | 8 | 0 | 10 546 |
| Savings certificates | 1 025 | 0 | 0 | 0 | 1 025 |
| Non-convertible bonds | 13 756 | 183 | 2 200 | 0 | 16 139 |
| Non-convertible subordinated liabilities | 2 327 | 0 | 147 | 0 | 2 474 |
| Repos | 2 565 | 0 | 0 | 0 | 2 565 |
| with credit institutions and investment firms | 2 262 | 0 | 0 | 0 | 2 262 |
| with customers | 302 | 0 | 0 | 0 | 303 |
| Liabilities under investment contracts | 0 | 0 | 13610 | 0 | 13610 |
| Derivatives | 0 | 5 057 | 0 | 1 171 | 6 227 |
| Short positions | 0 | 1 708 | 0 | 0 | 1 708 |
| In equity instruments | 0 | 14 | 0 | 0 | 14 |
| In debt securities | 0 | 1 693 | 0 | 0 | 1 693 |
| Other | 2 190 | O | 0 | 0 | 2 190 |
| Total | 224 093 | ୧ ୨୫୫ | 16 149 | 1 171 | 248 400 |
Deposits from credit institutions and investment firms' include funding obtained from the ECB's TLTRO programme. In 2Q 2020, KBC participated in TLTRO III for an amount of 19.5 billion euros.
| 31-12-2019 | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | Carrying value before impairment |
Impairment | Carrying value after impairment |
Carrying value before impairment |
Impairment | Carrying value after impairment |
| FINANCIAL ASSETS AT AMORTISED COST | ||||||
| Loans and advances (*) | 193 207 | - 3 589 | 189 618 | 189 446 | - 2 855 | 186 592 |
| Stage 1 (12-month ECL) | 169 002 | - 179 | 168 823 | 165 326 | - 131 | 165 195 |
| Stage 2 (lifetime ECL) | 19 011 | - 942 | 18 069 | 18 558 | - 254 | 18 304 |
| Stage 3 (lifetime ECL) | 5 049 | - 2 449 | 2 600 | 5 381 | - 2 444 | 2 937 |
| Purchased or originated credit impaired assets (POCI) |
146 | - 20 | 126 | 182 | - 26 | 155 |
| Debt Securities | 47 105 | - 12 | 47 093 | 43 010 | - 12 | 42 998 |
| Stage 1 (12-month ECL) | 47 068 | - 6 | 47 062 | 42 934 | - 5 | 42 930 |
| Stage 2 (lifetime ECL) | 31 | - 1 | 30 | 69 | - 2 | 67 |
| Stage 3 (lifetime ECL) | 7 | - 6 | 1 | 7 | - 6 | 1 |
| Purchased or originated credit impaired assets (POCI) |
0 | 0 | 0 | 0 | 0 | 0 |
| FINANCIAL ASSETS AT FAIR VALUE THROUGH OCI | ||||||
| Debt Securities | 18 333 | - 9 | 18 324 | 18 793 | - 5 | 18 788 |
| Stage 1 (12-month ECL) | 18 221 | - 7 | 18 214 | 18 771 | - 4 | 18 767 |
| Stage 2 (lifetime ECL) | 112 | - 3 | 110 | 22 | - 1 | 22 |
| Stage 3 (lifetime ECL) | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 | 0 | 0 | 0 |
(*) The carrying value after impairment in this note is equal to the sum of the lines Loans and advances to credit institutions and investment firms (excl. reverse repos), Loans and advances to customers (excl. reverse repos) and Reverse repos in note 4.1 (in the column Measured at amortised cost)
The table does not include the stage transfers embedded underlying in the management overlay of the forecasted collective Covid-19 ECL, as these are determined based on a collective statistical approach and hence cannot be individually linked to specific credits. Taking into account the impact of the management overlay on staging would result in a carrying value before impairment of loans and advances of approximately respectively 161, 26 and 7 billion euros in stage 1, 2 and 3 (or a net staging of approximately 5% of the total portfolio from stage 1 to stage 2 and of 1% from stage 1 & 2 to stage 3). For more information see note 1.4 in this report.
For more details on how KBC defines and determines (i) fair value and the fair value hierarchy and (ii) level 3 valuations reference is made to notes 4.4 up to and including 4.7 of the annual accounts 2019.
| (in millions of EUR) | 30-09-2020 | 31-12-2019 | ||||||
|---|---|---|---|---|---|---|---|---|
| Fair value hierarchy | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
| 0 | ||||||||
| FINANCIAL ASSETS AT FAIR VALUE | ||||||||
| Mandatorily measured at fair value through profit or loss (other than held for trading) |
14 332 | 368 | 437 | 15 138 | 15 536 | 441 | 320 | 16 298 |
| Held for trading | 2 985 | 6 890 | 1 047 | 10 922 | 1 685 | 4 381 | 1 200 | 7 266 |
| Fair value option | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| At fair value through OCI | 14 469 | 3 585 | 548 | 18 603 | 14 945 | 3 630 | 463 | 19 037 |
| Hedging derivatives | 0 | 198 | 0 | 198 | 0 | 158 | 0 | 158 |
| Total | 31 787 | 11 041 | 2 033 | 44 861 | 32 166 | 8 611 | 1 982 | 42 759 |
| FINANCIAL LIABILITIES AT FAIR VALUE | ||||||||
| Held for trading | 1 413 | 4 127 | 1 224 | 6 764 | 1 708 | 3 259 | 2 021 | 6 988 |
| Designated at fair value | 12 481 | 474 | 1 174 | 14 129 | 13 610 | 657 | 1 883 | 16 149 |
| Hedging derivatives | 0 | 1 387 | 0 | 1 387 | 0 | 1 171 | 0 | 1 171 |
| Total | 13 894 | 5 988 | 2 398 | 22 280 | 15 317 | 5 087 | 3 903 | 24 308 |
During 9M 2020, KBC transferred about 61 million euros' worth of financial assets and liabilities out of level 1 and into level 2. It also reclassified approximately 330 million euros' worth of financial assets and liabilities from level 2 to level 1. Most of these reclassifications were carried out due to a change in the liquidity of government and corporate bonds.
In 9M 2020 significant movements in financial assets and liabilities classified in level 3 of the fair value hierarchy included the following:
On 6 October 2011, Irving H. Picard, trustee for the liquidation of Bernard L. Madoff Investments Securities LLC (& Bernard L. Madoff), sued KBC Investments Ltd (a wholly-owned subsidiary of KBC Bank) before the bankruptcy court in New York to recover (claw-back) approximately USD 110,000,000 which had been transferred from Madoff (via a feeder fund KBC had lent to called Harley) to KBC entities. This claim is one of a whole set made by the trustee against several banks, hedge funds, feeder funds and investors ("joint defense group").
A lengthy litigation process was conducted on the basis of preliminary objections in respect of the applicability of the Bankruptcy Code's 'safe harbor' and 'good defenses' rules to subsequent transferees (as is the case for KBC Investments Ltd), as detailed in previous disclosures. In June 2015 the trustee amended the original claim which led to an increase of the amount claimed to USD 196,000,000.
A final court ruling dismissing the claim of the Trustee was issued on 3 March 2017. The Trustee appealed and the Court of Appeal reversed the dismissal on 28 February 2019. A petition (i.e. writ of Certioriari) filed on 30 August 2019 was denied by the U.S. Supreme Court on 2 June 2020. As a consequence the merits of the case will be handled by the Bankruptcy Court.
KBC still believes there is a strong basis to get the action against KBC dismissed as there are a number of other defenses that can be raised together with the joint defense group. The procedure may still take several years.
| Quantities | 30-09-2020 | 31-12-2019 |
|---|---|---|
| Ordinary shares | 416 394 642 | 416 394 642 |
| of which ordinary shares that entitle the holder to a dividend payment | 416 394 642 | 416 394 642 |
| of which treasury shares | 21 575 | 38 607 |
| Additional information | ||
| Par value per share (in EUR) | 3.51 | 3.51 |
| Number of shares issued but not fully paid up | O | O |
The ordinary shares of KBC Group NV have no nominal value and are quoted on NYSE Euronext (Brussels).
The treasury shares almost fully relate to positions in shares of KBC Group to hedge outstanding equity derivatives.
On 29 May 2020, KBC Insurance and Nova Ljubljanska banka ('NLB') closed the transaction announced on 27 December 2019 to sell, in a joint process, their respective stakes in the Slovenian 50/50 life insurance joint venture NLB Vita.
The transaction had a negligible impact on KBC Group's P&L and capital ratio.
On 31 May 2019, ČSOB has acquired the remaining 45% stake in ČMSS from Bausparkasse Schwäbisch Hall (BSH) for a total consideration of 240 million euros. As a result, ČMSS is as of 1 June 2019 fully consolidated (previously equity method).
Significant non-adjusting events between the balance sheet date (30 September 2020) and the publication of this report (12 November 2020): None


Additional Information 3Q 2020 and 9M 2020

Section not reviewed by the Auditor
The main source of credit risk is the loan portfolio of the bank. A snapshot of the banking portfolio is shown in the table below. It includes all payment credit, guarantee credit and standby credit granted by KBC to private persons, companies, governments and banks. Bonds held in the investment portfolio are included if they are corporate- or bank-issued, hence government bonds and trading book exposure are not included. Further on in this chapter, extensive information is provided on the credit portfolio of each business unit. Information specifically on sovereign bonds can be found under 'How do we manage our risks (in the annual accounts 2019)'.
| Credit risk: loan portfolio overview | 30-09-2020 | 31-12-2019 |
|---|---|---|
| Total loan portfolio (in billions of EUR) 1 | ||
| Amount outstanding and undrawn | 222 | 218 |
| Amount outstanding | 179 | 175 |
| Loan portfolio breakdown by business unit (as a % of the outstanding portfolio) | ||
| Belgium | 65.1% | 64.1% |
| Czech Republic | 17.2% | 18.4% |
| International Markets | 15.8% | 15.6% |
| Group Centre | 1.9% | 2.0% |
| Loan portfolio breakdown by counterparty sector (as a % of the outstanding portfolio) | ||
| Private individuals Finance and insurance Governments Corporates Services Distribution |
41.6% 8.3% 3.6% 46.4% 10.8% 6.8% |
41.7% 7.6% 2.9% 47.7% 10.9% 7.3% |
| Real estate Building & construction Agriculture, farming, fishing Automotive Food producers |
6.3% 3.9% 2.7% 2.5% 1.7% |
6.4% 3.9% 2.7% 2.6% 1.7% |
| Electricity Metals Chemicals Machinery & heavy equipment Hotels, bars & restaurants Shipping Oil, gas & other fuels |
1.6% 1.4% 1.4% 1.0% 0.7% 0.7% 0.5% |
1.6% 1.4% 1.3% 1.0% 0.7% 0.8% 0.6% |
| Electrotechnics Traders Other 2 Loan portfolio breakdown by region (as a % of the outstanding portfolio) |
0.5% 0.5% 3.3% |
0.5% 0.6% 3.6% |
| Home countries Belgium Czech Republic Ireland Slovakia Hungary Bulgaria Rest of Western Europe |
86.5% 54.1% 16.3% 5.8% 5.0% 3.2% 2.1% 8.7% |
86.4% 52.9% 17.6% 5.9% 4.9% 3.1% 2.0% 8.6% |
| Rest of Central and Eastern Europe | 0.3% | 0.4% |
| North America | 1.5% | 1.5% |
| Asia | 1.4% | 1.5% |
| Other | 1.6% | 1.6% |
| Loan portfolio breakdown by counterparty (as % of the outstanding portfolio) | ||
| Retail | 41.6% | 41.7% |
| of which: mortgages | 38.5% | 38.5% |
| of which: consumer finance | 3.1% | 3.2% |
| SME | 21.5% | 21.8% |
| Corporate | 36.9% | 36.5% |
| 30-09-2020 | 31-12-2019 | |
|---|---|---|
| Loan portfolio breakdown by IFRS 9 ECL stage (as % of the outstanding portfolio) | ||
| Stage 1 (credit risk has not increased significantly since initial recognition) | 85.4% | 85.2% |
| of which: PD 1 - 4 | 63.6% | 62.7% |
| of which: PD 5 - 9 including unrated | 21.8% | 22.6% |
| Stage 2 (credit risk has increased significantly since initial recognition – not credit impaired) incl. POCI 3 | 11.4% | 11.3% |
| of which: PD 1 - 4 | 3.5% | 3.4% |
| of which: PD 5 - 9 including unrated | 7.9% | 7.9% |
| Stage 3 (credit risk has increased significantly since initial recognition – credit impaired) incl. POCI 3 | 3.2% | 3.5% |
| of which: PD 10 impaired loans | 1.3% | 1.6% |
| of which: more than 90 days past due (PD 11+12) | 1.8% | 1.9% |
| Impaired loan portfolio (in millions of EUR) | ||
| Impaired loans (PD10 + 11 + 12) | 5 702 | 6 160 |
| of which: more than 90 days past due | 3 307 | 3 401 |
| Impaired loans ratio (%) | ||
| Belgium | 2.2% | 2.4% |
| Czech Republic | 2.1% | 2.3% |
| International Markets | 7.2% | 8.5% |
| Group Centre | 12.1% | 12.4% |
| Total | 3.2% | 3.5% |
| of which: more than 90 days past due | 1.8% | 1.9% |
| Loan loss impairment (in millions of EUR) | ||
| Loan loss Impairment for Stage 1 portfolio | 202 | 144 |
| Loan loss Impairment for Stage 2 portfolio | 950 | 265 |
| Loan loss Impairment for Stage 3 portfolio | 2 576 | 2 584 |
| of which: more than 90 days past due | 2 040 | 2 050 |
| Cover ratio of impaired loans (%) | ||
| Loan loss impairments for stage 3 portfolio / impaired loans | 45.2% | 42.0% |
| of which: more than 90 days past due | 61.7% | 60.3% |
| Cover ratio of impaired loans, mortgage loans excluded (%) | ||
| Loan loss impairments for stage 3 portfolio / impaired loans, mortgage loans excluded | 53.4% | 49.7% |
| of which: more than 90 days past due | 71.9% | 71.7% |
| Credit cost ratio (%) | ||
| Belgium | 0.59% | 0.22% |
| Czech Republic | 0.64% | 0.04% |
| International Markets | 0.79% | -0.07% |
| Slovakia | 0.53% | 0.14% |
| Hungary | 0.89% | -0.02% |
| Bulgaria | 0.81% | 0.14% |
| Ireland | 0.94% | -0.32% |
| Group Centre | -0.27% | -0.88% |
| Total | 0.61% | 0.12% |
1 Outstanding portfolio includes all on-balance sheet commitments and off-balance sheet guarantees but excludes off-balance sheet undrawn commitments; the amounts are measured in Gross Carrying Amounts;
2 Other includes corporate sectors not exceeding 0.5% concentration and unidentified sectors
3 Purchased or originated credit impaired assets
Impaired loans are loans for which full (re)payment of the contractual cash flows is deemed unlikely. This coincides with KBC's Probability-of-Default-classes 10, 11 and 12 (see annual accounts FY 2019 - section on credit risk for more information on PD classification). These impaired loans are equal to 'non-performing loans' under the definition used by EBA.
Since 1Q18 a switch has been made in the reported 'outstanding' figures from drawn principal to the new IFRS 9 definition of gross carrying amount (GCA), i.e. including reserved and accrued interests. The additional inclusion of reserved interests led, among others, to an increase in the reported amount of impaired loans. Furthermore, the transaction scope of the credit portfolio was extended and now additionally includes the following 4 elements: (1) bank exposure (money market placements, documentary credit, accounts), (2) debtor risk KBC Commercial Finance, (3) unauthorized overdrafts, and (4) reverse repo (excl. central bank exposure).
| Loa ort fol io B usi s U nit Be lgiu n p nes m |
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| 30- 09- 202 0, i illio of EU R n m ns |
1 Be lgiu m |
For | eig n b che ran |
s | Tot al B |
usi s U nit Be nes |
lgiu m |
||
| fol Tot al p ort io o uts tan din g |
109 24 8 |
7 2 62 |
116 51 0 |
||||||
| Co unt arty bre ak dow erp n |
% o uts t. |
% o uts t. |
% o uts t. |
||||||
| il reta |
38 351 |
35, 1% |
0 | 0,0 % |
38 351 |
32, 9% |
|||
| /w rtga o mo ges |
36 679 |
33, 6% |
0 | 0,0 % |
36 679 |
31, 5% |
|||
| /w er f ina o con sum nce |
1 6 72 |
1,5 % |
0 | 0,0 % |
1 6 72 |
1,4 % |
|||
| SM E |
31 598 |
28, 9% |
0 | 0,0 % |
31 598 |
27, 1% |
|||
| ate cor por |
39 299 |
36, 0% |
7 2 62 |
100 ,0% |
46 561 |
40, 0% |
|||
| Mo rtga loa ge ns |
% o uts t. |
ind . LT V |
% o uts t. |
ind . LT V |
% o uts t. |
||||
| tota l |
36 679 |
33, 6% |
57% | 0 | 0,0 % |
- | 36 679 |
31, 5% |
|
| /w FX rtga o mo ges |
0 | 0,0 % |
- | 0 | 0,0 % |
- | 0 | 0,0 % |
|
| /w ind . LT V > 10 0% o |
549 | 0,5 % |
- | 0 | 0,0 % |
- | 549 | 0,5 % |
|
| Pro bab ility of def aul t (P D) |
% o uts t. |
% o uts t. |
% o uts t. |
||||||
| low ris k (P D 1 -4; 0.0 0% -0.8 0% ) |
85 078 |
77, 9% |
4 0 02 |
55, 1% |
89 080 |
76, 5% |
|||
| diu isk (PD 5-7 ; 0. 80% -6.4 0% ) me m r |
18 883 |
17, 3% |
2 9 29 |
40, 3% |
21 811 |
18, 7% |
|||
| hig h ri sk (PD 8-9 ; 6. 40% -10 0.0 0% ) |
2 6 00 |
2,4 % |
145 | 2,0 % |
2 7 45 |
2,4 % |
|||
| imp aire d lo (P D 1 0 - 12) ans |
2 4 20 |
2,2 % |
179 | 2,5 % |
2 6 00 |
2,2 % |
|||
| ate d unr |
266 | % 0,2 |
8 | % 0,1 |
274 | % 0,2 |
|||
| Ov ll ri sk ind ica tor era s |
3 im sta ge p. |
% c ove r |
3 im sta ge p. |
% c ove r |
3 im sta ge p. |
% c ove r |
|||
| ndi imp aire d lo out sta ng ans |
2 4 20 |
1 0 80 |
44, 6% |
179 | 126 | 70, 4% |
2 6 00 |
1 2 06 |
46, 4% |
| /w PD 10 im pai red loa o ns |
1 1 49 |
274 | 23, 8% |
89 | 42 | 47, 3% |
1 2 38 |
316 | 25, 5% |
| /w re t han 90 da t du e (P D 1 1+1 2) o mo ys pas |
1 2 71 |
806 | 63, 4% |
90 | 84 | 93, 2% |
1 3 61 |
890 | 65, 4% |
| all imp airm ent s (s tag e 1 +2+ 3) |
1 6 72 |
163 | 1 8 35 |
||||||
| PO /w sta 1+2 im pai nts (in cl. CI) o ge rme |
592 | 37 | 629 | ||||||
| /w (in PO CI) sta 3 im pai nts cl. o ge rme |
1 0 80 |
126 | 1 2 06 |
||||||
| 201 9 C red it c io ( CC R) ost rat |
0,2 0% |
0,4 1% |
0,2 2% |
||||||
| YT D 2 020 CC R |
0,5 8% |
0,7 5% |
0,5 9% |
, p 1 Belgium = KBC Bank (all retail and corporate credit lending activities except for the foreign branches, part of non-legacy portfolio assigned to BU Belgium), CBC, KBC Lease Belgium, KBC Immolease and KBC Commercial Finance
art
| Tot al p ort fol io o uts tan din g |
30 781 |
||
|---|---|---|---|
| Co unt arty bre ak dow erp n |
% o uts t. |
||
| il reta |
17 888 |
58, 1% |
|
| /w rtga o mo ges |
15 733 |
1% 51, |
|
| /w er f ina o con sum nce |
2 1 55 |
7,0 % |
|
| SM E |
4 6 36 |
15, 1% |
|
| ate cor por |
8 2 58 |
26, 8% |
|
| Mo rtga loa ge ns |
% o uts t. |
ind . LT V |
|
| tota l |
15 733 |
51, 1% |
60% |
| /w FX rtga o mo ges |
0 | 0,0 % |
- |
| /w ind . LT V > 10 0% o |
105 | 0,3 % |
- |
| Pro bab ility of def aul t (P D) |
% o uts t. |
||
| k (P D 1 0.0 0% -0.8 0% ) low ris -4; |
17 857 |
58, 0% |
|
| diu isk (PD 5-7 ; 0. 80% -6.4 0% ) me m r |
11 060 |
35, 9% |
|
| hig h ri sk (PD 8-9 ; 6. 40% -10 0.0 0% ) |
1 1 98 |
3,9 % |
|
| imp aire d lo (P D 1 0 - 12) ans |
654 | 2,1 % |
|
| ate d unr |
13 | 0,0 % |
|
| 1 Ov ll ri sk ind ica tor era s |
sta 3 im ge p. |
% c ove r |
|
| out sta ndi imp aire d lo ng ans |
654 | 322 | 49, 2% |
| /w PD 10 im pai red loa o ns |
317 | 99 | 31, 3% |
| /w han 90 da t du e (P D 1 1+1 2) re t o mo ys pas |
337 | 223 | 66, 1% |
| all imp airm ent s (s tag e 1 +2+ 3) |
584 | ||
| /w sta 1+2 im pai nts (inc l. P OC I) o ge rme |
262 | ||
| /w sta 3 im pai nts (inc l. P OC I) o ge rme |
322 | ||
| 201 9 C red it co st r atio (C CR ) |
0,0 4% |
||
| YT D 2 020 CC R |
0,6 4% |
1 CCR at country level in local currency
| 30-0 9-20 20, in m illio f EU R ns o |
Irela nd |
Slov akia |
Hun gary |
Bulg aria |
Tota | l Int Ma rket s |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tota l po rtfo lio o and ing utst |
10 1 81 |
8 59 8 |
5 69 4 |
3 74 9 |
28 2 21 |
||||||||||
| Cou nter part y br eak dow n |
% o utst |
% o utst |
% o utst |
% o utst |
% o utst |
||||||||||
| reta il |
10 1 18 |
99,4 % |
4 54 6 |
52,9 % |
2 08 2 |
36,6 % |
1 47 8 |
39,4 % |
18 2 23 |
64,6 % |
|||||
| /w m ortg o age s |
10 0 53 |
% 98,7 |
4 05 3 |
% 47,1 |
1 59 1 |
% 27,9 |
780 | % 20,8 |
16 4 77 |
% 58,4 |
|||||
| /w c r fin o ons ume anc e |
65 | 0,6% | 492 | 5,7% | 491 | 8,6% | 698 | % 18,6 |
1 74 6 |
6,2% | |||||
| SME | 53 | 0,5% | 990 | 11,5 % |
150 | 2,6% | 1 06 9 |
28,5 % |
2 26 2 |
8,0% | |||||
| orat corp e |
10 | 0,1% | 3 06 2 |
35,6 % |
3 46 2 |
60,8 % |
1 20 2 |
32,1 % |
7 73 6 |
27,4 % |
|||||
| Mor e lo tgag ans |
% o utst |
ind. LTV |
% o utst |
ind. LTV |
% o utst |
ind. LTV |
% o utst |
ind. LTV |
% o utst |
||||||
| tota l |
10 0 53 |
98,7 % |
67% | 4 05 3 |
47,1 % |
65% | 1 59 1 |
27,9 % |
54% | 780 | 20,8 % |
65% | 16 4 77 |
58,4 % |
|
| /w F X m ortg o age s |
0 | 0,0% | - | 0 | 0,0% | - | 3 | 0,1% | 84% | 81 | 2,1% | 67% | 84 | 0,3% | |
| /w in d. L TV > 100 % o |
713 | 7,0% | - | 36 | 0,4% | - | 90 | 1,6% | - | 30 | 0,8% | - | 869 | 3,1% | |
| Prob abil ity o f de faul t (P D) |
% o utst |
% o utst |
% o utst |
% o utst |
% o utst |
||||||||||
| low risk (PD 1-4 ; 0.0 0%- 0.80 %) |
896 | 8,8% | 5 55 0 |
64,6 % |
2 86 3 |
50,3 % |
961 | 25,6 % |
10 2 71 |
36,4 % |
|||||
| med ium risk (PD 5-7 ; 0.8 0%- 6.40 %) |
6 94 6 |
68,2 % |
2 28 4 |
26,6 % |
2 49 7 |
43,9 % |
2 18 9 |
58,4 % |
13 9 16 |
49,3 % |
|||||
| high risk (PD 8-9 ; 6.4 0%- 100 .00% ) |
869 | 8,5% | 592 | 6,9% | 222 | 3,9% | 281 | 7,5% | 1 96 4 |
7,0% | |||||
| impa ired loa ns ( PD 10 - 12) |
1 46 9 |
14,4 % |
151 | 1,8% | 103 | 1,8% | 318 | 8,5% | 2 04 0 |
7,2% | |||||
| ted unra |
0 | 0,0% | 21 | 0,2% | 10 | 0,2% | 0 | 0,0% | 31 | 0,1% | |||||
| 1 Ove rall risk ind icat ors |
stag e 3 imp |
% c ove r |
stag e 3 imp. |
% c ove r |
stag e 3 imp |
% c ove r |
stag e 3 imp. |
% c ove r |
stag e 3 imp |
% c ove r |
|||||
| outs tand ing impa ired loa ns |
1 46 9 |
402 | 27,4 % |
151 | 95 | 62,8 % |
103 | 58 | 57,0 % |
318 | 137 | 43,2 % |
2 04 0 |
693 | 34,0 % |
| /w P D 10 imp aire d lo o ans |
670 | 82 | 12,3 % |
25 | 7 | 29,1 % |
22 | 8 | 36,1 % |
66 | 11 | 16,3 % |
784 | 108 | 13,8 % |
| /w m than 90 day st d ue ( PD 11+ 12) o ore s pa |
799 | 320 | 40,1 % |
125 | 87 | 69,6 % |
81 | 50 | 62,7 % |
251 | 126 | 50,3 % |
1 25 6 |
584 | 46,5 % |
| all im pair ts (s tage 1+2 +3) men |
479 | 172 | 132 | 167 | 950 | ||||||||||
| /w s tage 1+2 imp airm ents (inc l. PO CI) o |
76 | 78 | 73 | 30 | 257 | ||||||||||
| /w s tage 3 im pair ts (i ncl. POC I) o men |
402 | 95 | 58 | 137 | 693 | ||||||||||
| 9 Cr o (C CR) 201 edit cost rati |
2% -0,3 |
% 0,14 |
2% -0,0 |
% 0,14 |
7% -0,0 |
||||||||||
| 0 CC YTD 202 R |
% 0,94 |
% 0,53 |
% 0,89 |
% 0,81 |
% 0,79 |
Remarks
1 CCR at country level in local currency
| % o utst |
ind. LT V |
|
|---|---|---|
| 0 | 0,0% | - |
| 0 | 0,0% | - |
| 0 | 0,0% | - |
| % o utst |
||
| 2 78 7 |
82,7 % |
|
| 132 | 3,9% | |
| 42 | 1,2% | |
| 409 | 12,1 % |
|
| 0 | 0,0% | |
| stag e 3 imp |
% c ove r |
|
| 409 | 355 | 86,9 % |
| 56 | 12 | 22,2 % |
| 353 | 343 | 97,2 % |
| 359 | ||
| 4 | ||
| 355 | ||
| -0,8 8% |
||
| -0,2 7% |
||
3 370
0
0
% outst.
0,0%
0,0%
0,0%
0,0%
100,0%
1 Total Group Centre = part of non-legacy portfolio assigned to BU Group and activities in wind-down (e.g. ex-Antwerp Diamond Bank)
KBC reports its solvency at group, banking and insurance level, calculating it on the basis of IFRS figures and the relevant guidelines issued by the competent regulator.
We report the solvency of the group, the bank and the insurance company based on IFRS data and according to the rules imposed by the regulator. For the KBC group, this implies that we calculate our solvency ratios based on CRR/CRD IV. This regulation entered gradually into force on 1 January 2014. The general rule under CRR/CRD IV for insurance participations is that an insurance participation is deducted from common equity at group level, unless the competent authority grants permission to apply a risk weighting instead (Danish compromise). KBC received such permission from the supervisory authority and hence reports its solvency on the basis of a 370% risk weighting being applied to the holdings of own fund instruments of the insurance company, after having deconsolidated KBC Insurance from the group figures.
In addition to the solvency ratios under CRD IV/CRR, KBC is considered a financial conglomerate since it covers both significant banking and insurance activities. Therefore KBC also has to disclose its solvency position as calculated in accordance with the Financial Conglomerate Directive (FICOD; 2002/87/EC). This implies that available capital is calculated on the basis of the consolidated position of the group and the eligible items recognised as such under the prevailing sectorial rules, which are CRR/CRD IV for the banking business and Solvency II for the insurance business. The capital requirement for the insurance business based on Solvency II is multiplied by 12.5 to obtain a risk weighted asset equivalent.
The Internal Rating Based (IRB) approach is since its implementation in 2008 the primary approach to calculate KBC's risk weighted assets. This is, based on a full application of all the CRD IV/CRR rules, used for approximately 93% of the weighted credit risks, of which approx. 89% according to Advanced and approx. 4% according to Foundation approach. The remaining weighted credit risks (ca. 7%) are calculated according to the Standardised approach.
The overall capital requirement (CET1) that KBC is to uphold is set at 10.45% (fully loaded, Danish Compromise which includes the CRR/CRD IV minimum requirement (4.5%), the Pillar 2 Requirement (1.75%) and the buffers set by national competent authorities (2.50% Capital Conservation Buffer, 1.50% Systemic Buffer and 0.20% Countercyclical Buffer). Furthermore ECB has set a Pillar 2 Guidance of 1.00%.
ECB temporarily allows banks to operate below the P2G and Capital Conservation Buffer and hence to use these buffers to withstand potential stress. This temporarily brings the regulatory minimum to 7.95% (being 10.45% – 2.5%). ECB does not have any discretion to waive the application of automatic restrictions to distributions (MDA) as they are set out in the CRR/CRD package. Therefore, the CCB remains included in the threshold for MDA.
(1) Fully in line with the European Central Bank recommendation that at least till January 2021 no dividends are paid out and no irrevocable commitment to pay out dividends is undertaken by the credit institutions for the financial year 2019 and 2020 and that credit institutions refrain from share buy-backs.
Distributions (being dividend payments, payments related to additional tier 1 instruments or variable remuneration) are limited in case the combined buffer requirements described above are breached. This limitation is also referred to as "Maximum Distributable Amount" or "MDA" thresholds.
The table below provides an overview of the buffers KBC Group has compared to these thresholds, both on an actuals basis (i.e. versus the regulatory targets that apply at the reporting date) and a fully loaded basis (i.e. versus the regulatory targets that will apply going forward).
| Buffer vs. Overall Capital Requirement (in millions of EUR) |
30-09-2020 | 31-12-2019 | ||
|---|---|---|---|---|
| (consolidated, under CRR/CRD IV, Danish compromise method) |
Fully loaded |
Actuals | Fully loaded |
Actuals |
| CET1 Pillar 1 minimum | 4.50% | 4.50% | 4.50% | 4.50% |
| Pillar 2 requirement | 1.75% | 1.75% | 1.75% | 1.75% |
| Capital conservation buffer | 2.50% | 2.50% | 2.50% | 2.50% |
| Buffer for systemically important institutions (O-SII) | 1.50% | 1.50% | 1.50% | 1.50% |
| Entity-specific countercyclical buffer | 0.20% | 0.16% | 0.30% | 0.43% |
| Overall Capital Requirement (OCR) | 10.45% | 10.41% | 10.55% | 10.68% |
| CET1 used to satisfy shortfall in AT1 bucket | 0.00% | 0.00% | 0.00% | 0.00% |
| CET1 used to satisfy shortfall in T2 bucket | 0.23% | 0.23% | 0.05% | 0.05% |
| CET1 requirement | 10.69% | 10.65% | 10.60% | 10.74% |
| CET1 capital | 16 579 | 16 606 | 16 989 | 16 989 |
| CET1 buffer (= buffer to MDA) | 5 875 | 5 939 | 6 486 | 6 353 |
Following table groups the solvency on the level of KBC Group according to different methodologies and calculation methods, including the deduction method.
| Overview of KBC Group's capital ratios (in millions of EUR) |
numerator (common |
denominator (total weighted risk |
||
|---|---|---|---|---|
| 30-09-2020 | equity) | volume) | ratio (%) | |
| CRDIV, Common Equity ratio | ||||
| Danish Compromise | Fully loaded | 16 579 | 100 169 | 16.55% |
| Deduction Method | Fully loaded | 15 774 | 95 195 | 16.57% |
| Financial Conglomerates Directive | Fully loaded | 17 283 | 111 486 | 15.50% |
| Danish Compromise | Transitional | 16 606 | 100 191 | 16.57% |
| Deduction Method | Transitional | 15 801 | 95 216 | 16.60% |
| Financial Conglomerates Directive | Transitional | 17 311 | 111 507 | 15.52% |
KBC's CET1 ratio of 16.55% at end 9M 2020 represents a solid capital buffer:
| 30-09-2020 | 30-09-2020 | 31-12-2019 | |
|---|---|---|---|
| In millions of EUR | Fully loaded | Transitional | Fully loaded |
| Total regulatory capital (after profit appropriation) | 19 849 | 19876 | 20 414 |
| Tier-1 capital | 18 079 | 18 106 | 18 489 |
| Common equity | 16 579 | 16 606 | 16 989 |
| Parent shareholders' equity (after deconsolidating KBC Insurance) | 17 553 | 17 553 | 17 933 |
| Intangible fixed assets, incl deferred tax impact (-) | - 807 | - 807 | - 726 |
| Goodwill on consolidation, incl deferred tax impact (-) | - 718 | - 718 | 766 |
| Minority interests | O | O | O |
| Hedging reserve (cash flow hedges) (-) | 1 321 | 1 321 | 1 331 |
| Valuation diff. in financial liabilities at fair value - own credit risk (-) | - 12 | - 12 | - 9 |
| Value adjustment due to the requirements for prudent valuation (-) | - 26 | - 26 | - 54 |
| Dividend payout (-) | O | O | O |
| Coupon of AT1 instruments (-) | - 15 | - 15 | - 11 |
| Deduction re. financing provided to shareholders (-) | - 57 | - 57 | 57 l |
| Deduction re. Irrevocable payment commitments (-) | - 58 | - 58 | - 45 |
| IRB provision shortfall (-) | - 214 | - 214 | - 140 |
| Deferred tax assets on losses carried forward (-) | - 388 | - 388 | - 467 |
| Transitional adjustments to CET1 | O | 27 | |
| Limit on deferred tax assets from timing differences relying on future profitability and | O | 0 | O |
| significant participations in financial sector entities (-) | |||
| Additional going concern capital | 1 500 | 1 500 | 1 500 |
| CRR compliant AT1 instruments | 1 500 | 1 500 | 1 500 |
| Minority interests to be included in additional going concern capital | O | O | O |
| Tier 2 capital | 1 770 | 1 770 | 1 925 |
| IRB provision excess (+) | O | O | 130 |
| Transitional adjustments to T2 | |||
| Subordinated liabilities | 1 770 | 1 770 | 1 795 |
| Subordinated loans non-consolidated financial sector entities (-) | 0 | 0 | 0 |
| Minority interests to be included in tier 2 capital | 0 | O | O |
| Total weighted risk volume | 100 169 | 100 191 | 99 071 |
| Banking | 91 019 | 91 040 | 89 838 |
| Insurance | 9 133 | 9 133 | 9 133 |
| Holding activities | 29 | 29 | 124 |
| Elimination of intercompany transactions | - 12 | - 12 | - 25 |
| Solvency ratios | |||
| Common equity ratio | 16.55% | 16.57% | 17.15% |
| Tier-1 ratio | 18.05% | 18.07% | 18.66% |
| Total capital ratio | 19.82% | 19.84% | 20.61% |
In line with the ECB recommendation we apply the IFRS 9 transitional measures as of 1H 2020. The impact of transitional was limited to 2 basis points at the end of 9M 2020 as there was no interim profit recognition in CET1. At year-end 2020, the impact of the application of the transitional measures is expected to result in a positive impact on CET1 of 56 bps compared to fully loaded.
| Leverage ratio KBC Group (Basel III) In millions of EUR |
30-09-2020 | 30-09-2020 | 31-12-2019 |
|---|---|---|---|
| Fully loaded | Transitional | Fully loaded | |
| Tier-1 capital (Danish compromise) | 18 079 | 18 106 | 18 489 |
| Total exposures | 304 188 | 304 229 | 273 029 |
| Total Assets | 321 193 | 321 193 | 290 735 |
| Deconsolidation KBC Insurance | -31 760 | -31 760 | -33 243 |
| Transitional adjustment | 0 | 41 | 0 |
| Adjustment for derivatives | -5 225 | -5 225 | -2 882 |
| Adjustment for regulatory corrections in determining Basel III Tier-1 capital | -2 268 | -2 268 | -2 254 |
| Adjustment for securities financing transaction exposures | 2 247 | 2 247 | 638 |
| Off-balance sheet exposures | 20 000 | 20 000 | 20 035 |
| Leverage ratio | 5.94% | 5.95% | 6.77% |
As is the case for the KBC group, the solvency of KBC Bank is calculated based on CRR/CRD IV. The solvency of KBC Insurance is calculated on the basis of Solvency II rules as they became effective on 1 January 2016. The tables below show the tier-1 and CAD ratios calculated under Basel III (CRD IV/CRR) for KBC Bank, as well as the solvency ratio of KBC Insurance under Solvency II.
| KBC Bank consolidated - CRDIV/CRR | 30-09-2020 | 30-09-2020 | 31-12-2019 |
|---|---|---|---|
| (in millions of EUR) | Fully loaded | Transitional Fully loaded | |
| Total regulatory capital, after profit appropriation | 16 138 | 16 165 | 16 660 |
| Tier-1 capital | 14 345 | 14 372 | 14 704 |
| Of which common equity | 12 845 | 12872 | 13 204 |
| Tier-2 capital | 1 793 | 1 793 | 1 957 |
| Total weighted risks | 91 019 | 91 040 | 89 838 |
| Credit risk | 77 067 | 77 088 | 75 786 |
| Market risk | 2611 | 2 611 | 2 713 |
| Operational risk | 11 340 | 11 340 | 11 340 |
| Solvency ratios | |||
| Common equity ratio | 14.1% | 14.1% | 14.7% |
| Tier-1 ratio | 15.8% | 15.8% | 16.4% |
| CAD ratio | 17.7% | 17.8% | 18.5% |
| Solvency II, KBC Insurance consolidated (in millions of EUR) |
30-09-2020 | 31-12-2019 |
|---|---|---|
| Own Funds | 3 214 | 3 496 |
| Tier 1 | 2 714 | 2 996 |
| IFRS Parent shareholders equity | 3 578 | 3 422 |
| Dividend payout | - 307 | - 156 |
| Deduction intangible assets and goodwill (after tax) | - 133 | - 128 |
| Valuation differences (after tax) | - 578 | - 196 |
| Volatility adjustment | 173 | 104 |
| Other | - 19 | - 49 |
| Tier 2 | 500 | 500 |
| Subordinated liabilities | 500 | 500 |
| Solvency Capital Requirement (SCR) | 1 636 | 1 727 |
| Market risk | 1 214 | 1 389 |
| Non-life | 581 | 579 |
| Life | 709 | 689 |
| Health | 290 | 264 |
| Counterparty | 127 | 114 |
| Diversification | -1 000 | - 991 |
| Other | - 285 | - 316 |
| Solvency II ratio | 196% | 202% |
Besides the ECB and NBB, which supervise KBC on a going concern basis, KBC is also subject to requirements set by the Single Resolution Board (SRB). The SRB is developing resolution plans for the major banks in the euro area. The resolution plan for KBC is based on a Single Point of Entry (SPE) approach at the level of KBC Group with 'bail-in' as the primary resolution tool. MREL measures the amount of own funds and eligible liabilities that can be credibly and feasibly bailed-in.
The Eligible instruments to satisfy the MREL target are defined in the '2018 SRB Policy for the 2nd wave of resolution plans' published on 16th January 2019. The so-called 'consolidated approach' (instruments issued by any entity within the resolution group were accepted by SRB to satisfy the MREL target) is replaced by a more restrictive 'hybrid approach'. This approach excludes MREL eligible liabilities that have not been issued by KBC Group NV (insofar as they do not constitute own funds) and requires tier-2 capital down-streamed by KBC Group NV to KBC Insurance to be deducted from MREL (in line with the treatment under CRR/CRD). At year-end 2019, 1 billion euro of instruments were no longer eligible for SRB to satisfy the MREL.
At the end of September 2020, the MREL ratio based on instruments issued by KBC Group NV following the 'hybrid approach' stands at 9.4% of TLOF versus the SRB requirement for KBC to achieve 9.67% as by year-end 2021.
The decrease of the MREL as a % of TLOF (versus 10.0% at the end of March 2020), can be fully explained by the participation in TLTRO III for an amount of 19.5 billion euros in June 2020. Excluding this, the MREL as % of TLOF would have amounted to 10.1% at the end of September 2020.
As of 1H 2020, the MREL ratio as a % of TLOF includes the impact of IFRS 9 transitional measures.
Details on our segments or business units are available in the company presentation.
Note: The ECB approved to apply the IFRS9 transitional arrangements from 2Q 2020, as such the difference between fully loaded and the transitional measures are assigned to Group Centre. In other words, the RWA, allocated capital and the ROAC of the different countries remain based on fully loaded.
| Business unit Belgium | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2020 2Q 2020 1Q 2020 4Q 2019 3Q 2019 | ||||
| Breakdown P&L | |||||
| Net interest income | 673 | 635 | 640 | 634 | 637 |
| Non-life insurance (before reinsurance) | 157 | 167 | 112 | 160 | 129 |
| Earned premiums | 287 | 280 | 283 | 285 | 284 |
| Technical charges | - 130 | - 113 | - 172 | - 125 | 156 |
| Life insurance (before reinsurance) | - 16 | - 16 | - 21 | 21 | 25 |
| Earned premiums | 191 | 208 | 216 | 282 | 217 |
| Technical charges | - 206 | - 224 | 237 | 303 | 242 |
| Ceded reinsurance result | - 3 | - 10 | - 9 | 10 | 5 I |
| Dividend income | 10 | 16 | 11 | 15 | 14 |
| Net result from financial instruments at fair value through profit or loss | 67 | 149 | 217 | 89 | 9 - |
| Net realised result from debt instruments at fair value through OCI | 1 | 1 | O | O | ব |
| Net fee and commission income | 271 | 271 | 308 | 307 | 297 |
| Net other income | 36 | 45 | 35 | 41 | 51 |
| TOTAL INCOME | 1 197 | 1 256 | 858 | 1 216 | 1 092 |
| Operating expenses | - 520 | 521 | 828 | 550 | 552 |
| Impairment | - 43 | 469 | 117 | 109 | 21 |
| on financial assets at AC and at FVOCI | - 41 | 458 | 116 | 107 | 21 |
| other | 2 - |
- 11 | 0 | 2 I |
0 |
| Share in results of associated companies and joint ventures | 2 । |
- 3 | 3 - |
2 - |
2 - |
| RESULT BEFORE TAX | 633 | 264 | 90 | 556 | 517 |
| Income tax expense | 147 | ਦਰ | 4 | 145 | 149 |
| RESULT AFTER TAX | 486 | 204 | 86 | 412 | 368 |
| attributable to minority interests | O | O | O | O | 0 |
| attributable to equity holders of the parent | 486 | 204 | 86 | 412 | 368 |
| Banking | 352 | 68 | ട് ട | 301 | 287 |
| Insurance | 134 | 136 | 30 | 111 | 81 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 103 844 | 103 689 | 104 969 | 100 909 | 100 945 |
| of which Mortgage loans (end of period) | 37 717 | 36 863 | 36 489 | 36 445 | 35 832 |
| Customer deposits and debt certificates excl. repos (end of period) | 137 271 | 136 928 | 138 045 | 130 771 | 134 355 |
| Technical provisions plus unit-linked, life insurance | |||||
| Interest Guaranteed (end of period) | 12 944 | 13 005 | 13 074 | 13 130 | 13 097 |
| Unit-Linked (end of period) | 12 576 | 12 599 | 12 064 | 13 426 | 13 281 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 53 363 | 52 938 | 54 098 | 49 486 | 49 985 |
| Required capital, insurance (end of period) | 1 393 | 1 358 | 1 296 | 1 497 | 1 572 |
| Allocated capital (end of period) | 6 970 | 6 943 | 7 003 | 6 792 | 6 920 |
| Return on allocated capital (ROAC) | 28% | 12% | -5% | 24% | 22% |
| Cost/income ratio, banking | 47% | 44% | 95% | 48% | 53% |
| Combined ratio, non-life insurance | 81% | 74% | 95% | 82% | 91% |
| Net interest margin, banking | 1.63% | 1.63% | 1.68% | 1.68% | 1.68% |
| Business unit Czech Republic | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2020 2Q 2020 1Q 2020 4Q 2019 3Q 2019 | ||||
| Breakdown P&L | |||||
| Net interest income | 220 | 235 | 351 | 338 | 329 |
| Non-life insurance (before reinsurance) | 36 | 38 | 31 | 30 | 29 |
| Earned premiums | 78 | 72 | 75 | 73 | 72 |
| Technical charges | - 42 | 35 | 44 | 43 | 43 |
| Life insurance (before reinsurance) | 12 | 12 | 14 | 12 | 13 |
| Earned premiums | 50 | 44 | 52 | 58 | ર્ટિક |
| Technical charges | - 38 | 32 | 33 | 45 | 40 |
| Ceded reinsurance result | 1 | O | 0 | O | 0 |
| Dividend income | O | 0 | O | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 16 | 90 | 125 | 8 | રક |
| Net realised result from debt instruments at fair value through OCI | O | 1 | O | 0 | O |
| Net fee and commission income | 52 | 51 | 55 | રેત્વે છે. વિત્તાના વિત્તાના પાકની ખેત | 70 |
| Net other income | 3 | 3 | 9 | 3 | 2 |
| TOTAL INCOME | 337 | 431 | 335 | 451 | 388 |
| Operating expenses | - 179 | 164 | 221 | 200 | 187 |
| Impairment | - 18 | 175 | 9 - |
- 3 | 9 |
| on financial assets at AC and at FVOCI | 15 | 170 | 8 - |
1 | 9 |
| other | 3 - |
- 5 | 1 | 1 - |
0 |
| Share in results of associated companies and joint ventures | O | O | 0 | O | 0 |
| RESULT BEFORE TAX | 139 | 91 | 105 | 248 | 192 |
| Income tax expense | - 23 | 14 | 17 | - 43 | 33 l |
| RESULT AFTER TAX | 116 | 77 | 88 | 205 | 159 |
| attributable to minority interests | O | O | O | O | 0 |
| attributable to equity holders of the parent | 116 | 77 | 88 | 205 | 159 |
| Banking | 104 | 61 | 75 | 194 | 147 |
| Insurance | 12 | 16 | 13 | 11 | 12 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 28 106 | 28 597 | 28 286 | 29 857 | 29 200 |
| of which Mortgage loans (end of period) | 15384 | 15 418 | 14 876 | 15 768 | 15 267 |
| Customer deposits and debt certificates excl. repos (end of period) | 39 162 | 39 704 | 37 627 | 39 559 | 38 170 |
| Technical provisions plus unit-linked, life insurance | |||||
| Interest Guaranteed (end of period) | 622 | 613 | 588 | 629 | 616 |
| Unit-Linked (end of period) | 615 | 659 | ୧୧୧ | 727 | 700 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 14 971 | 15 338 | 15 349 | 15 005 | 14 916 |
| 131 | 128 | 126 | 121 | 121 | |
| Required capital, insurance (end of period) | 1 696 | 1 746 | 1 745 | 1 726 | 1 717 |
| Allocated capital (end of period) | 27% | 18% | 20% | 48% | |
| Return on allocated capital (ROAC) | 38% | ||||
| Cost/income ratio, banking | 54% 90% |
38% 81% |
68% 90% |
44% 94% |
48% |
| Combined ratio, non-life insurance Net interest margin, banking |
2.05% | 2.32% | 2.98% | 2.90% | 94% 2.93% |
| Business unit International Markets | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2020 2Q 2020 1Q 2020 4Q 2019 3Q 2019 | ||||
| Breakdown P&L | |||||
| Net interest income | 227 | 219 | 219 | 219 | 216 |
| Non-life insurance (before reinsurance) | 34 | 46 | 40 | 35 | 32 |
| Earned premiums | 81 | 78 | 82 | 80 | 80 |
| Technical charges | - 47 | 33 | 43 | 45 | 48 |
| Life insurance (before reinsurance) | 4 | 10 | 8 | 11 | 7 |
| Earned premiums | 25 | 24 | 29 | 24 | 21 |
| Technical charges | - 21 | - 15 | 21 | - 14 | 14 |
| Ceded reinsurance result | 1 | 3 | 3 | 1 | 2 |
| Dividend income | O | O | 0 | O | 0 |
| Net result from financial instruments at fair value through profit or loss | 18 | 14 | 5 | 23 | 5 |
| Net realised result from debt instruments at fair value through OCI | O | 1 | 0 | O | 1 |
| Net fee and commission income | 68 | 67 | ea | 78 | 77 |
| Net other income | - 4 | 5 | 6 | য | 16 |
| TOTAL INCOME | 347 | 359 | 333 | 370 | 321 |
| Operating expenses | - 200 | 196 | - 268 | - 248 | 212 |
| Impairment | 1 | 213 | - 24 | 18 | 6 - |
| on financial assets at AC and at FVOCI | 6 | 217 | 6 - |
22 | 5 |
| other | 5 । |
4 | 18 | 4 | 1 |
| Share in results of associated companies and joint ventures | 0 | O | 0 | 1 | 1 |
| RESULT BEFORE TAX | 148 | 50 | 42 | 141 | 104 |
| Income tax expense | - 24 | 5 | 7 - |
- 22 | 19 l |
| RESULT AFTER TAX | 123 | 45 | 35 | 119 | 85 |
| attributable to minority interests | O | O | O | O | 0 |
| attributable to equity holders of the parent | 123 | 45 | 35 | 119 | 85 |
| Banking | 112 | દિવેલ | 19 | 107 | 75 |
| Insurance | 11 | 21 | 16 | 12 | 11 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 25824 | 25 277 | 25 109 | 25 050 | 24 718 |
| of which Mortgage loans (end of period) | 15952 | 15 650 | 15 536 | 15 584 | 15 357 |
| Customer deposits and debt certificates excl. repos (end of period) | 24 789 | 24 272 | 23 197 | 24 041 | 22 939 |
| Technical provisions plus unit-linked, life insurance | |||||
| Interest Guaranteed (end of period) | 250 | 254 | 254 | 255 | 258 |
| Unit-Linked (end of period) | 390 | 397 | 373 | 432 | 414 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 20 791 | 20 736 | 21 507 | 20 892 | 21 068 |
| Required capital, insurance (end of period) | 130 | 127 | 123 | 124 | 123 |
| Allocated capital (end of period) | 2 302 | 2 315 | 2 391 | 2 359 | 2 377 |
| Return on allocated capital (ROAC) | 21% | -8% | 6% | 20% | 14% |
| Cost/income ratio, banking | 58% | 57% | 84% | 68% | 67% |
| Combined ratio, non-life insurance | 89% | 75% | 82% | 89% | 93% |
| Net interest margin, banking | 2.61% | 2.58% | 2.61% | 2.60% | 2.61% |
| Slovakia | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2020 2Q 2020 1Q 2020 4Q 2019 3Q 2019 | ||||
| Breakdown P&L | |||||
| Net interest income | 52 | 49 | 50 | 51 | 51 |
| Non-life insurance (before reinsurance) | 7 | 8 | 7 | 7 | 7 |
| Earned premiums | 13 | 13 | 12 | 12 | 12 |
| Technical charges | - 6 | 4 - |
5 | 5 | 5 - |
| Life insurance (before reinsurance) | 3 | 3 | 3 | 4 | 2 |
| Earned premiums | 9 | 8 | 9 | 12 | 10 |
| Technical charges | 5 - |
5 | / | 7 | 7 |
| Ceded reinsurance result | 7 | 1 | O | 1 | 0 |
| Dividend income | O | 0 | 0 | O | 0 |
| Net result from financial instruments at fair value through profit or loss | 6 | 7 | 8 - |
10 | 5 - |
| Net realised result from debt instruments at fair value through OCI | O | 1 | 0 | O | 0 |
| Net fee and commission income | 15 | 14 | 15 | 16 | 16 |
| Net other income | 7 | 2 | 3 | 4 | 2 |
| TOTAL INCOME | 84 | 84 | 70 | ત્ત્વે ઉત્પત્તર તે જીરુ, જીરુ, જીરુ, જીરુ, જીરુ, જીરુ, જીરુ, તેમ જ દૂધની ડેરી જેવી સવલતો પ્રાપ્ય થયેલી છે. આ ગામનાં લોકોનો મુખ્ય વ્યવસાય ખેતી, ખેતમજૂરી તેમ જ પશુપાલન છે. આ ગ | 74 |
| Operating expenses | - 46 | 51 | ಕಾ | 53 | 52 |
| Impairment | 5 | 41 | 6 - |
6 | ഗ - |
| on financial assets at AC and at FVOCI | 5 | 41 | 6 | 5 | ഗ - |
| other | 0 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | O | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 43 | 8 | 4 | 46 | 16 |
| Income tax expense | 10 | 2 | 1 | 8 | 4 - |
| RESULT AFTER TAX | 33 | ട | ব | 38 | 12 |
| attributable to minority interests | O | 0 | 0 | O | 0 |
| attributable to equity holders of the parent | 33 | હ l |
4 | 38 | 12 |
| Banking | 30 | ತಿ | 1 | રૂદિ | 10 |
| Insurance | 3 | 3 | 3 | 2 | 2 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 7 857 | 7 683 | 7 607 | 7 506 | 7 471 |
| of which Mortgage loans (end of period) | 3 992 | 3 846 | 3714 | 3 641 | 3 593 |
| Customer deposits and debt certificates excl. repos (end of period) | 7 100 | 6 531 | 6 287 | 6 480 | 6 438 |
| Technical provisions plus unit-linked, life insurance | |||||
| Interest Guaranteed (end of period) | 114 | 114 | 114 | 114 | 114 |
| Unit-Linked (end of period) | 87 | 92 | 89 | 100 | 97 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 5011 | 5 104 | 5 123 | 4 985 | 5 030 |
| Required capital, insurance (end of period) | 28 | 27 | 26 | 27 | 28 |
| Allocated capital (end of period) | 552 | ട്ട് ട | 567 | 560 | 566 |
| Return on allocated capital (ROAC) | 24% | -5% | 3% | 27% | 8% |
| Cost/income ratio, banking | 54% | 62% | 88% | 56% | 71% |
| Combined ratio, non-life insurance | 87% | 79% | 82% | 94% | 84% |
| Hungary | 3Q 2020 2Q 2020 1Q 2020 4Q 2019 3Q 2019 | ||||
|---|---|---|---|---|---|
| (in millions of EUR) Breakdown P&L |
|||||
| Net interest income | 68 | 64 | 62 | 64 | 64 |
| Non-life insurance (before reinsurance) | 12 | 17 | 14 | 14 | 10 |
| Earned premiums | 35 | 35 | રૂત્વ | 37 | રૂદ |
| Technical charges | - 24 | - 17 | 25 | 22 | 26 |
| Life insurance (before reinsurance) | 2 - |
2 | 1 | 2 | 2 |
| Earned premiums | 9 | 8 | 9 | 4 | 4 |
| Technical charges | - 11 | ଚ | 8 | 2 | 2 |
| Ceded reinsurance result | 1 - |
1 | 1 | 0 | 1 |
| Dividend income | O | O | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 12 | 10 | 2 | 9 | 6 |
| Net realised result from debt instruments at fair value through OCI | O | O | 0 | 0 | 1 |
| Net fee and commission income | 46 | 46 | 49 | 56 | 55 |
| Net other income | O | O | 2 | O | 0 |
| TOTAL INCOME | 136 | 140 | 130 | 146 | 137 |
| Operating expenses | 74 | ea | 101 | 87 | 83 |
| Impairment | 2 - |
50 | 16 | 3 | 1 |
| on financial assets at AC and at FVOCI | 3 | 55 | 2 | 2 | 1 |
| other | 5 । |
6 | 18 | 1 | 0 |
| Share in results of associated companies and joint ventures | O | 0 | O | 0 | 0 |
| RESULT BEFORE TAX | 59 | 21 | 13 | 57 | 53 |
| Income tax expense | - 9 | 5 | 4 - |
7 | 8 - |
| RESULT AFTER TAX | 51 | 16 | 10 | 50 | 45 |
| attributable to minority interests | O | O | 0 | O | 0 |
| attributable to equity holders of the parent | 51 | 16 | 10 | 50 | 45 |
| Banking | 46 | 7 | 2 | 44 | 41 |
| Insurance | 4 | 9 | 8 | ട | 4 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 4 775 | 4 617 | 4 534 | 4 623 | 4 522 |
| of which Mortgage loans (end of period) | 1 541 | 1 512 | 1 467 | 1 596 | 1 558 |
| Customer deposits and debt certificates excl. repos (end of period) | 7 983 | 8 011 | 7 435 | 7 953 | 7 140 |
| Technical provisions plus unit-linked, life insurance | |||||
| Interest Guaranteed (end of period) | 46 | 49 | 48 | 52 | 52 |
| Unit-Linked (end of period) | 251 | 258 | 243 | 291 | 280 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 6 895 | 6 865 | 6 555 | 6 415 | 6 480 |
| Required capital, insurance (end of period) | 45 | 47 | 44 | 48 | 47 |
| Allocated capital (end of period) | 766 | 772 | 735 | 735 | 740 |
| Return on allocated capital (ROAC) | 27% | 8% | 5% | 27% | 24% |
| Cost/income ratio, banking | 56% | 52% | 82% | 61% | 62% |
| Combined ratio, non-life insurance | 92% | 76% | 84% | 87% | 96% |
| Bulgaria | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2020 2Q 2020 1Q 2020 4Q 2019 3Q 2019 | ||||
| Breakdown P&L | |||||
| Net interest income | 36 | રૂદિ | રૂદ | રૂદ | રેક |
| Non-life insurance (before reinsurance) | 15 | 20 | 18 | 13 | 15 |
| Earned premiums | 32 | 31 | 31 | 31 | 32 |
| Technical charges | - 17 | - 11 | 13 | 18 | 17 |
| Life insurance (before reinsurance) | 3 | 5 | য | ব | 3 |
| Earned premiums | 7 | 9 | 11 | 9 | 8 |
| Technical charges | 4 - |
4 | 7 | 4 | 5 - |
| Ceded reinsurance result | O | 1 | 2 | 0 | 2 |
| Dividend income | O | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | O | 0 | 0 | 3 | 4 |
| Net realised result from debt instruments at fair value through OCI | O | O | 0 | 0 | 0 |
| Net fee and commission income | 8 | 6 | 6 | 5 | 6 |
| Net other income | 1 | 1 | 0 | 1 | 1 |
| TOTAL INCOME | e3 | 67 | 62 | દર્ડ | દિર |
| Operating expenses | 31 - |
27 | 48 | 33 | 30 |
| Impairment | 2 | 25 | 3 | 0 | ഗ - |
| on financial assets at AC and at FVOCI | 2 | 23 | 3 | ব | 6 - |
| other | 0 | 1 | 0 | 3 | 0 |
| Share in results of associated companies and joint ventures | O | O | 0 | 0 | 0 |
| RESULT BEFORE TAX | 30 | 16 | 11 | 31 | 26 |
| Income tax expense | 3 | 2 | 1 - |
3 | 3 - |
| RESULT AFTER TAX | 27 | 14 | 10 | 27 | 23 |
| attributable to minority interests | O | O | O | O | O |
| attributable to equity holders of the parent | 27 | 14 | 10 | 27 | 23 |
| Banking | 22 | 4 | 4 | 24 | 20 |
| Insurance | 5 | 9 | 6 | 3 | 3 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 3413 | 3 307 | 3 213 | 3 161 | 3 064 |
| of which Mortgage loans (end of period) | 752 | 723 | 703 | 693 | 675 |
| Customer deposits and debt certificates excl. repos (end of period) | 4 802 | 4 634 | 4 497 | 4 439 | 4 216 |
| Technical provisions plus unit-linked, life insurance | |||||
| Interest Guaranteed (end of period) | 90 | 91 | 92 | 89 | 91 |
| Unit-Linked (end of period) | 52 | 47 | 41 | 41 | 37 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 3 133 | 3 073 | 3 770 | 3 413 | 3 338 |
| Required capital, insurance (end of period) | 57 | રૂડે | ર્કિક | 49 | 48 |
| Allocated capital (end of period) | 384 | 377 | 450 | 414 | 405 |
| Return on allocated capital (ROAC) | 27% | 13% | 9% | 27% | 24% |
| Cost/income ratio, banking | 49% | 44% | 86% | 51% | 47% |
| Combined ratio, non-life insurance | 85% | 70% | 82% | 89% | 91% |
| Ireland | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2020 2Q 2020 1Q 2020 4Q 2019 3Q 2019 | ||||
| Breakdown P&L | |||||
| Net interest income | 72 | ട്ടു | 71 | 67 | દિક |
| Non-life insurance (before reinsurance) | O | O | O | O | 0 |
| Earned premiums | O | O | 0 | O | 0 |
| Technical charges | O | O | 0 | 0 | 0 |
| Life insurance (before reinsurance) | O | O | 0 | 0 | 0 |
| Earned premiums | 0 | O | 0 | 0 | 0 |
| Technical charges | O | 0 | 0 | 0 | 0 |
| Ceded reinsurance result | O | 0 | 0 | 0 | 0 |
| Dividend income | 0 | O | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 1 | 3 | 2 | 0 | 0 |
| Net realised result from debt instruments at fair value through OCI | 0 | O | 0 | O | 0 |
| Net fee and commission income | 1 - |
0 | 1 - |
0 | 0 |
| Net other income | 6 - |
O | 0 | 1 | 18 |
| TOTAL INCOME | 64 | 65 | 71 | 67 | 48 |
| Operating expenses | 49 1 |
48 | 60 | 75 | 47 |
| Impairment | 0 | 97 | 2 | 14 | 7 |
| on financial assets at AC and at FVOCI | 0 | 97 | 1 | 14 | 7 |
| other | 0 | O | 0 | O | 0 |
| Share in results of associated companies and joint ventures | O | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 15 | 80 | 13 | 6 | 8 |
| Income tax expense | 2 | 10 | 2 | 3 | 3 |
| RESULT AFTER TAX | 13 | 70 | 12 | 2 | 4 |
| attributable to minority interests | O | O | O | 0 | 0 |
| attributable to equity holders of the parent | 13 | 70 | 12 | 2 | 4 |
| Banking | 14 | ୧୫ । |
12 | 2 | 4 |
| Insurance | - 1 | - 1 | O | 0 | 0 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 9779 | 9670 | 9 754 | 9 760 | 9 661 |
| of which Mortgage loans (end of period) | 9 666 | 9 569 | 9 651 | 9 654 | 9 531 |
| Customer deposits and debt certificates excl. repos (end of period) | 4 904 | 5 095 | 4 978 | 5 169 | 5 145 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 5 750 | 5 692 | 6 057 | 6 077 | 6 216 |
| Allocated capital (end of period) | 601 | 600 | ୧39 | 650 | ୧୧୮ |
| Return on allocated capital (ROAC) | 8% | -44% | 7% | 1% | 3% |
| Cost/income ratio, banking | 75% | 72% | 83% | 113% | 98% |
| Group Centre - Breakdown net result | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2020 2Q 2020 1Q 2020 4Q 2019 3Q 2019 | ||||
| Operational costs of the Group activities | - 20 | 18 । |
- 15 | - 34 | - 14 |
| Capital and treasury management | 7 | ട | 11 | - 8 | |
| Holding of participations | 2 | 3 | - 2 | ||
| Results companies in rundown | য ા |
ന | 2 | 12 | |
| Other | - 8 | 18 । |
க | 9 | |
| Total net result for the Group centre | - 28 | 26 ၊ |
- 43 | - 33 | O |
| Business unit Group Centre | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2020 2Q 2020 1Q 2020 4Q 2019 3Q 2019 | ||||
| Breakdown P&L | |||||
| Net interest income | 2 | റ | 16 | 9 | రి |
| Non-life insurance (before reinsurance) | 7 | 5 | 2 | 4 | 2 |
| Earned premiums | 3 | 4 | 2 | 2 | 3 |
| Technical charges | 4 | 1 | 0 | 1 | 2 |
| Life insurance (before reinsurance) | O | O | 0 | 0 | 0 |
| Earned premiums | 0 | 0 | 0 | 0 | 0 |
| Technical charges | 0 | 0 | 0 | 0 | 0 |
| Ceded reinsurance result | 4 | 1 | 5 | 0 | 1 |
| Dividend income | 1 | 1 | 1 | 1 | 0 |
| Net result from financial instruments at fair value through profit or loss | - 16 | 1 | 39 | 10 | 14 |
| Net realised result from debt instruments at fair value through OCI | 0 | 0 | 0 | 0 | 0 |
| Net fee and commission income | 1 | 1 | 2 | 0 | 0 |
| Net other income | 1 | 0 | 0 | 2 | 5 |
| TOTAL INCOME | 9 - |
2 - |
48 | 4 | 12 |
| Operating expenses | 27 | 24 | 21 | 48 | 23 |
| Impairment | 2 - |
0 | 9 | 11 | 10 |
| on financial assets at AC and at FVOCI | 2 | 0 | 9 | 11 | 10 |
| other | 0 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 38 | 26 | 60 | 32 | 1 |
| Income tax expense | 10 | 0 | 18 | 1 - |
1 |
| RESULT AFTER TAX | 28 | 26 | 43 | 33 | 0 |
| attributable to minority interests | 0 | 0 | 0 | O | 0 |
| attributable to equity holders of the parent | - 28 | 26 । |
- 43 | 33 | 0 |
| Banking | 22 | 21 | 49 | 17 | 5 |
| Holding | - 6 | 5 | 3 | 26 | 1 |
| Insurance | 0 | 0 | 4 | 10 | 4 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 0 | 0 | 0 | 1 | 0 |
| of which Mortgage loans (end of period) | 0 | 0 | 0 | 0 | 0 |
| Customer deposits and debt certificates excl. repos (end of period) | 10 450 | 9 908 | 9 426 | 8 999 | 9 806 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 1 912 | 2 209 | 2 339 | 4 554 | 2 266 |
| Risk-weighted assets, insurance (end of period, Basel III fully loaded) | 9 133 | 9 133 | 9 133 | 9 133 | 9 133 |
| Required capital, insurance (end of period) | - 18 | - 15 | - 22 | - 15 | 2 |
| Allocated capital (end of period) | 182 | 218 | 224 | 473 | 245 |
Gives an idea of the amount of profit over a certain period that is attributable to one share (and, where applicable, including dilutive instruments).
| Calculation (in millions of EUR) | Reference | 9M 2020 | 2019 | 9M 2019 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) - |
Consolidated income statement' | 902 | 2 489 | 1 787 |
| Coupon on the additional tier-1 instruments included in equity (B) |
Consolidated statement of changes in equity' | - 37 | - 56 | - 43 |
| / | ||||
| Average number of ordinary shares less treasury shares (in millions) in the period (C) |
Note 5.10 | 416 | 416 | 416 |
| or Average number of ordinary shares plus dilutive options less treasury shares in the period (D) |
416 | 416 | 416 | |
| Basic = (A-B) / (C) (in EUR) | 2.08 | 5.85 | 4.19 | |
| Diluted = (A-B) / (D) (in EUR) | 2.08 | 5.85 | 4.19 |
Gives an insight into the technical profitability (i.e. after eliminating investment returns, among other items) of the non-life insurance business, more particularly the extent to which insurance premiums adequately cover claim payments and expenses. The combined ratio takes ceded reinsurance into account.
| Calculation (in millions of EUR or %) | Reference | 9M 2020 | 2019 | 9M 2019 |
|---|---|---|---|---|
| Technical insurance charges, including the internal cost of settling claims (A) |
Note 3.7.1 | 696 | 1 006 | 779 |
| / | ||||
| Earned insurance premiums (B) | Note 3.7.1 | 1 302 | 1 693 | 1 260 |
| + | ||||
| Operating expenses (C) | Note 3.7.1 | 404 | 526 | 398 |
| / | ||||
| Written insurance premiums (D) | Note 3.7.1 | 1 371 | 1 728 | 1 334 |
| = (A/B)+(C/D) | 82.9% | 89.9% | 91.7% |
A risk-weighted measure of the group's solvency based on common equity tier-1 capital (the ratios given here are based on the Danish compromise). The CRD IV rules are gradually being implemented to allow banks to build up the necessary capital buffers. The capital position of a bank, when account is taken of the transition period, is referred to as the 'phased-in' view. The capital position based on full application of all the rules – as would be the case after this transition period – is referred to as 'fully loaded'.
A detailed calculation can be found under 'Solvency KBC Group' section.
Gives an impression of the relative cost efficiency (costs relative to income) of the banking activities.
| Calculation (in millions of EUR or %) | Reference | 9M 2020 | 2019 | 9M 2019 |
|---|---|---|---|---|
| Cost/income ratio | ||||
| Operating expenses of the banking activities (A) / |
Consolidated income statement': component of 'Operating expenses' |
2 814 | 3 800 | 2 895 |
| Total income of the banking activities (B) | Consolidated income statement': component of 'Total income' |
4 596 | 6 563 | 4 813 |
| =(A) / (B) | 61.2% | 57.9% | 60.2% |
Where relevant, we also estimate exceptional and/or non‐operating items when calculating the cost/income ratio. This calculation aims to give a better idea of the relative cost efficiency of the pure business activities. The adjustments include: MTM ALM derivatives (fully excluded), bank taxes(including contributions to European Single Resolution Fund) are included pro rata and hence spread over all quarters of the year instead of being recognised for the most part upfront (as required by IFRIC 21) and one‐off items. The Cost/Income ratio adjusted for specific items is 59% in 9M 2020 (versus 58% in FY 2019 and 59% in 9M 2019).
Indicates the proportion of impaired loans (see 'Impaired loans ratio' for definition) that are covered by impairment charges. Where appropriate, the numerator and denominator in the formula may be limited to impaired loans that are more than 90 days past due.
| Calculation (in millions of EUR or %) | Reference | 9M 2020 | 2019 | 9M 2019 |
|---|---|---|---|---|
| Specific impairment on loans (A) | Credit risk: loan portfolio overview' table in the 'Credit risk' section |
2 576 | 2 584 | 2 601 |
| / Outstanding impaired loans (B) |
Credit risk: loan portfolio overview' table in the 'Credit risk' section |
5 702 | 6 160 | 6 197 |
| = (A) / (B) | 45.2% | 42.0% | 42.0% |
*based on YTD view
Gives an idea of loan impairment charges recognised in the income statement for a specific period, relative to the total loan portfolio (see 'Loan portfolio' for definition). In the longer term, this ratio can provide an indication of the credit quality of the portfolio.
| Calculation (in millions of EUR or %) | Reference | 9M 2020 | 2019 | 9M 2019 |
|---|---|---|---|---|
| Net changes in impairment for credit risks (A) / |
Consolidated income statement': component of 'Impairment' |
1 012 | 204 | 129 |
| Average outstanding loan portfolio (B) | Credit risk: loan portfolio overview' table in the 'Credit risk' section |
177 157 | 170 128 | 170 689 |
| = (A) (annualised) / (B) | 0.61% | 0.12% | 0.10% |
The credit cost ratio of 9M2020 includes a collective Covid‐19 expected credit loss (ECL) of 784 million euros, of which: (i) a total management overlay of 637 million euros and (ii) an impact of 147 million euros captured by our ECL models after 9 months. In the calculation of the credit cost ratio, the impact of the Covid‐19 ECL is excluded from annualisation. Without the Covid‐19 ECL impact, the credit cost ratio amounts to 0.17%.
Indicates the proportion of impaired loans in the loan portfolio (see 'Loan portfolio' for definition) and, therefore, gives an idea of the creditworthiness of the portfolio. Impaired loans are loans where it is unlikely that the full contractual principal and interest will be repaid/paid. These loans have a KBC default status of PD 10, PD 11 or PD 12 and correspond to the definition of 'nonperforming' used by the European Banking Authority.
| Calculation (in millions of EUR or %) | Reference | 9M 2020 | 2019 | 9M 2019 |
|---|---|---|---|---|
| Amount outstanding of impaired loans (A) | Credit risk: loan portfolio overview' table in the 'Credit risk' section |
5 702 | 6 160 | 6 197 |
| / Total outstanding loan portfolio (B) |
Credit risk: loan portfolio overview in the 'Credit risk' section |
178 883 | 175 431 | 176 553 |
| = (A) / (B) | 3.2% | 3.5% | 3.5% |
Gives an idea of the group's solvency, based on a simple non-risk-weighted ratio. A detailed calculation can be found under 'Solvency KBC Group' section.
Gives an idea of the bank's liquidity position in the short term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-month period. It is the average of 12 end-of-month LCR figures.
| Calculation (in millions of EUR or %) | Reference | 9M 2020 | 2019 | 9M 2019 |
|---|---|---|---|---|
| Stock of high-quality liquid assets (A) | Based on the European Commission's Delegated Act on LCR and the European Banking Authority's guidelines for LCR disclosure |
77 858 | 74 884 | 76 500 |
| / | ||||
| Total net cash outflows over the next 30 calendar days (B) |
55 057 | 54 415 | 54 750 | |
| = (A) / (B) | 142% | 138% | 140% |
Gives an idea of the magnitude of (what are mainly traditional) lending activities.
| Calculation (in millions of EUR or %) | Reference | 9M 2020 | 2019 | 9M 2019 |
|---|---|---|---|---|
| Loans and advances to customers (A) + |
Note 4.1, component of 'Loans and advances to customers' |
157 773 | 155 816 | 154 863 |
| Reverse repos (not with Central Banks) (B) | Note 4.1, component of 'Reverse repos with credit institutions and investment firms' |
3 886 | 1 559 | 4 008 |
| + | ||||
| Debt instruments issued by corporates and by credit institutions and investment firms (banking) (C) |
Note 4.1, component of 'Debt instruments issued by corporates and by credit institutions and investment firms' |
6 082 | 5 894 | 5 751 |
| + | ||||
| Other exposures to credit institutions (D) + |
4 236 | 4 629 | 4 954 | |
| Financial guarantees granted to clients and other commitments (E) |
Note 6.1, component of 'Financial guarantees given' |
8 254 | 8 160 | 8 076 |
| + | ||||
| Impairment on loans (F) | Note 4.2, component of 'Impairment' |
3 600 | 2 866 | 2 928 |
| + | ||||
| Insurance entities (G) | Note 4.1, component of 'Loans and advances to customers' |
- 2 251 | - 2 288 | - 2 308 |
| + | ||||
| Non-loan-related receivables (H) | - 1 465 | - 738 | - 715 | |
| + | ||||
| Other (I) | Component of Note 4.1 | - 1 233 | - 468 | - 1 005 |
| Gross Carrying amount = (A)+(B)+(C)+(D)+(E)+(F)+(G)+(H)+(I) | 178 883 | 175 431 | 176 553 |
Gives an idea of the net interest income of the banking activities (one of the most important sources of revenue for the group) relative to the average total interest-bearing assets of the banking activities.
| Calculation (in millions of EUR or %) | Reference | 9M 2020 | 2019 | 9M 2019 |
|---|---|---|---|---|
| Net interest income of the banking activities (A) / |
Consolidated income statement': component of 'Net interest income' |
2 866 | 3 853 | 2 867 |
| Average interest-bearing assets of the banking activities (B) | Consolidated balance sheet': component of 'Total assets' |
202 799 | 194 731 | 193 407 |
| = (A) (annualised x360/number of calendar days) / (B) | 1.86% | 1.95% | 1.95% |
The net interest margin takes into account the banking group net interest income, excluding dealing room and the net positive impact of ALM FX swaps & repos.
Gives an idea of the bank's structural liquidity position in the long term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-year period.
| Calculation (in millions of EUR or %) | Reference | 9M 2020 | 2019 | 9M 2019 |
|---|---|---|---|---|
| Available amount of stable funding (A) | Basel III, the net stable funding ratio (Basel Committee on Banking Supervision publication, October 2014) |
202 010 | 174 977 | 173 000 |
| / | ||||
| Required amount of stable funding (B) | 138 488 | 128 845 | 128 600 | |
| = (A) / (B) | 145.9% | 135.8% | 134.5% |
Gives the carrying value of a KBC share, i.e. the value in euros represented by each share in the parent shareholders' equity of KBC.
| Calculation (in millions of EUR or %) | Reference | 9M 2020 | 2019 | 9M 2019 |
|---|---|---|---|---|
| Parent shareholders' equity (A) | 'Consolidated balance sheet' | 19 384 | 18 865 | 18 086 |
| / | ||||
| Number of ordinary shares less treasury shares | Note 5.10 | 416 | 416 | 416 |
| (at period-end) (B) | ||||
| = (A) / (B) (in EUR) | 46.55 | 45.31 | 43.46 |
Gives an idea of the relative profitability of a business unit, more specifically the ratio of the net result to the capital allocated to the business unit.
| Calculation (in millions of EUR or %) | Reference | 9M 2020 | 2019 | 9M 2019 |
|---|---|---|---|---|
| BELGIUM BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) / |
Note 2.2: Results by segment | 605 | 1 344 | 932 |
| The average amount of capital allocated to the business unit is based on the risk-weighted assets for the banking activities (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
6 869 | 6 764 | 6 757 | |
| = (A) annualised / (B) | 11.7% | 19.9% | 18.4% | |
| CZECH REPUBLIC BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) / |
Note 2.2: Results by segment | 281 | 789 | 584 |
| The average amount of capital allocated to the business unit is based on the risk-weighted assets for the banking activities (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
1 711 | 1 692 | 1 683 | |
| = (A) annualised / (B) | 21.7% | 46.7% | 46.3% | |
| INTERNATIONAL MARKETS BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) / |
Note 2.2: Results by segment | 113 | 379 | 260 |
| The average amount of capital allocated to the business unit is based on the risk-weighted assets for the banking activities (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
2 318 | 2 354 | 2 352 | |
| = (A) annualised / (B) | 6.5% | 16.1% | 14.7% |
Gives an idea of the relative profitability of the group, more specifically the ratio of the net result to equity.
| Calculation (in millions of EUR or %) | Reference | 9M 2020 | 2019 | 9M 2019 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) |
Consolidated income statement' | 902 | 2 489 | 1 787 |
| - | ||||
| Coupon on the additional tier-1 instruments included in equity (B) / |
Consolidated statement of changes in equity' | - 37 | - 56 | - 44 |
| Average parent shareholders' equity, excluding the revaluation reserve for FVOCI instruments and for FVPL equity instruments – overlay approach (C) |
Consolidated statement of changes in equity' | 17 755 | 16 978 | 16 477 |
| = (A-B) (annualised) / (C) | 6.5% | 14.3% | 14.1% |
The return on equity amounts to 7% in 9M 2020 when including evenly spreading of the bank taxes throughout the year.
Gives the indication of the sales activities of life insurance products including unit-linked.
| Calculation (in millions of EUR or %) | Reference | 9M 2020 | 2019 | 9M 2019 |
|---|---|---|---|---|
| Life Insurance - earned premiums (before reinsurance) (A) | Consolidated income statement' | 841 | 1 323 | 959 |
| + | ||||
| Life insurance: difference between written and earned premiums (before reinsurance) (B) + |
- | 0 | 1 | 0 |
| Investment contracts without discretionary participation feature (large part of unit-linked) – margin deposit accounting (C) |
- | 567 | 525 | 419 |
| Total sales Life (A)+ (B) + (C) | 1 407 | 1 849 | 1 378 |
Measures the solvency of the insurance business, as calculated under Solvency II.
A detailed calculation can be found under 'Solvency banking and insurance activities separately' section.
Total assets under management (AuM) comprise third-party assets and KBC group assets managed by the group's various asset management companies (KBC Asset Management, ČSOB Asset Management, etc.), as well as assets under advisory management at KBC Bank. The assets, therefore, consist mainly of KBC investment funds and unit-linked insurance products, assets under discretionary and advisory management mandates of (mainly retail, private banking and institutional) clients, and certain group assets. The size and development of total AuM are major factors behind net fee and commission income (generating entry and management fees) and hence account for a large part of any change in this income line. In that respect, the AuM of a fund that is not sold directly to clients but is instead invested in by another fund or via a discretionary/advisory management portfolio, are also included in the total AuM figure, in view of the related work and any fee income linked to them.
| Calculation (in billions of EUR or quantity) | Reference | 9M 2020 | 2019 | 9M 2019 |
|---|---|---|---|---|
| Belgium Business Unit (A) | Company presentation on www.kbc.com | 188 | 200 | 197 |
| + | ||||
| Czech Republic Business Unit (B) | 11 | 11 | 10 | |
| + | ||||
| International Markets Business Unit (C) | 6 | 5 | 5 | |
| A)+(B)+(C) | 204 | 216 | 212 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.